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This thesis is divided into three parts.  The Review Paper (part 1) presents a 
systematic review of cognitive deficits in first episode psychosis.  It also examines the 
neurological basis for these deficits and their relation to social functioning.  The Review 
Paper highlights the need for more research to explore the possible link between 
cognitive deficits and social and community functioning in first episode psychosis.
The Empirical Paper (part 2) reports on a study I conducted, which examined the 
relationship between cognitive and community functioning in those with a first episode 
of psychosis.  Cognitive function was assessed by the measures that comprise the Brief 
Cognitive Assessment (Trail Making Test, Hopkins Verbal Learning Test and Verbal 
Fluency) and measures of Theory of Mind (Hints Task, Picture Sequencing Task and 
Theory of Mind Stories).  A global cognition score calculated from the BCA and the 
Hints Task were positively and significantly correlated with community functioning, as 
assessed by the Multnomah Community Ability Scale.
Finally, the Critical Appraisal (part 3) reflects on the process of conducting this 
research, including recruitment issues and the assessment measures used.  The strengths 





















Part 3:  Critical Appraisal
Title  101




Appendix 1: Inclusion criteria and instructions for referring clients to the study 116
Appendix 2: Client information sheet 118
Appendix 3: Letter of ethical approval 121
Appendix 4: Consent forms 125
Appendix 5: Report template 128
Appendix 6: Demographic information questionnaire 133
Tables
Table 1: Sample demographics 67
Table 2: Mean z-scores and standard deviations for the BCA subtests and GCFS 76
Table 3: Descriptive statistics for scores on the other measures 78
Table 4: Significance test for skewed variables 80
4Acknowledgements
Firstly, I would like to sincerely thank Graham Pickup for his expertise and 
support.  I could not have wished for a better supervisor.  I am indebted to the patients 
and staff from the early intervention in psychosis services who gave up their time and 
energy to make this research possible.  I would like to thank Kirk, my family and friends 
for propping me up throughout.  Finally, I would also like to thank my course mates for 
their encouragement and support.
5Part 1:  Review Paper
A Systematic Review of Cognitive Deficits in First Episode 
Psychosis, their Neurological Basis and their Relation to Social 
FunctioningReview Paper
Abstract
This review examines the research evidence for cognitive deficits in first episode 
psychosis (FEP), their neurological basis and their relation to social functioning. 
Twenty-six papers were identified by searching computer databases (e.g. PsycINFO, the 
Cochrane Library, etc.), hand searching relevant journals, and searching reference 
sections of key papers.  The papers identified were then categorised into 3 subject areas: 
neurological, cognitive deficits, and social functioning.  FEP patients showed an excess 
of neurological soft signs and differences in brain morphology compared to healthy 
controls.  While there appears to be clear evidence to support a generalised cognitive 
deficit in FEP, there may also be a sub-group of patients who have specific impairments 
in some aspects of cognitive function.  There appears to be little or no evidence of an 
association between cognitive deficits and social functioning in FEP, though this area 
requires further research in the future.
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1.1 Introduction
The purpose of this review is to examine the research evidence for cognitive 
deficits in first episode psychosis (FEP), their neurological basis and relation to social 
functioning.  Background information about psychosis is drawn together to establish a 
context for the review.  Following a review of the evidence, recommendations for 
future research in FEP are discussed.  For the purpose of this review, I shall use the term 
‘psychosis’ except where studies have specifically used the term ‘schizophrenia’.
1.1.1  What is psychosis?
Psychosis was first described as “dementia praecox” by Kraepelin in the fifth 
edition of his Textbook of  Psychiatry (Kraepelin, 1896).  This Latin term, meaning 
“senility of the young”, reflected a variety of symptoms which Kraepelin noted first 
appeared in adolescence or early adulthood.  These symptoms included catatonic 
postures, unusual perceptual experiences, attentional difficulties, inappropriate 
emotional responses and irrational beliefs.  As the name suggests, a common underlying 
feature of dementia praecox was deterioration in mental functions.  Kraepelin saw this 
process as neurodegenerative, whereby patients became mentally disabled, led 
unproductive lives and never recovered (Bentall, 2003).  In the century or so since this 
illness was first described, advances in science have led to different opinions regarding 
the trajectory for dementia praecox, or “schizophrenia” as it known today.  However, 
deterioration in mental functions remains a core feature of the illness (Wing, 1978).
“Psychosis” was a term used by Jaspers to differentiate a cluster of illnesses that 
were understood to stem from biological abnormalities (e.g. schizophrenia and manic 
depression) as opposed to illnesses that were believed to emanate from personality and
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life experiences which were known as “neuroses” (e.g. anxiety and depression where 
contact with reality is maintained) (Bentall, 2003).  Today the terms “schizophrenia” and 
“psychosis” are used interchangeably, and psychosis seems to be used more frequently 
than schizophrenia in the UK.  The signs and symptoms associated with psychosis are 
varied in their manifestations and course (Frith, 1992).  Some common symptoms 
include hearing voices in the second or third person, delusions of control or reference, 
paranoia, thought insertion, withdrawal and broadcast (Frith, 1992).  These symptoms 
are classified as "positive" symptoms because they represent the presence of abnormal 
experiences.  Other symptoms include poverty of speech, psychomotor retardation, flat 
affect and anhedonia (Sharma, 2000).  These symptoms are classed as “negative” 
symptoms as they characterise the absence of behaviour or function.  Positive symptoms 
usually occur early in psychosis and generally respond well to medication.  Negative 
symptoms often occur in the later stage of the illness and may be predictive of poor 
long-term outcome (McGlashan & Fenton, 1992).
1.1.2  Prevalence of psychosis
In the year 2000, 1  in 200 people had a psychotic disorder in the UK (Office for 
National Statistics, 2006).  Despite the low frequency of psychotic disorders in 
comparison to other conditions (e.g. neurotic disorders), people with psychotic disorders 
are more likely to be represented in services because of the nature and severity of the 
illness. In 2000, 83% of those with psychotic disorder were receiving pharmacological 
treatment, and 40% of these were receiving psychological treatment (Office for National 
Statistics, 2006).
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1.1.3  Causes of psychosis -  nature or nurture?
The exact cause of psychosis remains unknown.  The importance of genetic 
factors in the aetiology of schizophrenia has been known since the 1970s.  In a study of 
family risk of developing schizophrenia, the risk for siblings of those with schizophrenia 
was reported to be 11.5%.  Second degree relatives showed a risk of approximately 4% 
(Kallman, 1938).  This was one of the earliest studies, and the pooled results of other 
family studies since then suggest a slightly lower risk across all relatives of those with 
schizophrenia.  The children of mothers with schizophrenia were reported to have the 
same risk as the children of fathers with schizophrenia, while the children of two parents 
with schizophrenia were reported to have a risk of about 40% (Slater & Cowie, 1971). 
The incidence of schizophrenia in monozygotic twins was reported as being much 
greater than in dizygotic twins.  Kallmann (1946) reported overall concordance rates of 
69% for monozygotic twins and 10.3% for dizygotic twins.  The exact percentages vary 
between studies in the literature perhaps because of the heterogeneity and severity of the 
illness, and the different diagnostic criteria used.
In an attempt to disentangle environmental and genetic influences, some 
adoption studies were conducted.  Rosenthal et al. (1968) compared the children of 
biological parents with schizophrenia who were raised by adoptive parents with a 
matched control group of adoptees whose parents had no history of psychiatric illness. 
They found that the rate of spectrum diagnoses was significantly increased in the 
offspring of affected parents over that of the offspring of control parents.  This suggested 
that genetics plays a more powerful role in the genesis of schizophrenia than 
environment.  Relapse of psychosis has been shown to be higher in patients living in
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homes where critical comments, hostility and over involvement are common (Vaughn & 
Leff, 1976).  This is known as “expressed emotion”.
1.1.4  Causes of psychosis - neurological
When schizophrenia was first described in Kraepelin’s time, its cause was 
understood to stem from neuropathology.  Even though no abnormalities had been 
observed in the brains of patients with schizophrenia, neuropathologists continued to 
search diligently (Frith, 1992).  As time passed, with the lack of concrete evidence of 
neuropathology and the advent of alternative theories, many began to lose faith in the 
presence of a brain abnormality associated with schizophrenia.  However, this view was 
challenged with the discovery of antipsychotic drugs and the development of 
quantitative rather than qualitative studies of brain structure (Frith, 1992).
Many antipsychotic drugs have been developed since the 1950s, and although 
they all differ in terms of their basic chemistry, their therapeutic effectiveness appears to 
lie in blocking dopamine receptors (Seeman, Lee, Cahu-Wong, & Wong, 1976).  The 
precise role of dopamine in schizophrenia remains unclear; however, there is evidence to 
suggest that the dopaminergic receptors in the brains of schizophrenic patients are more 
sensitive than in healthy controls (Owen et al., 1978).  Although stimulation of the 
dopamine system has been found to produce symptoms of schizophrenia (Connell,
1958), there is no evidence to suggest that there is too much dopamine production in the 
brains of those suffering from schizophrenia (Crow et al., 1984).
The advent of Computerised Axial Tomography (CAT) in the 1970s led to 
increased interest in the brain structure of those with psychosis.  The measurement of the 
cross-sectional area of the lateral ventricles showed them to be significantly enlarged in
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a group of schizophrenic patients relative to controls (Johnstone, Crow, Frith, Husband,
& Kreel, 1976).  This is also common in Alzheimer’s disease; however, unlike 
schizophrenia the ventricles become enlarged in Alzheimers disease as tissue is lost 
(Frith, 1992).  The ventricles in schizophrenia are particularly enlarged within the 
temporal lobes on the left side of the brain (Crow et al., 1989), while adjacent parts of 
the cortex such as the hippocampus and parahippocampal gyrus have been shown to be 
reduced in size (Bogerts, Meartz, & Schofield-Bausch, 1985).  The enlarged ventricles 
have not been shown to become progressively larger over time (Gattaz, Kohlmeyer, & 
Gasser, 1991), and some researchers have found enlarged ventricles before the onset of 
symptoms (O’Callaghan et al., 1988; Weinberger, 1988).  This suggests that brain 
abnormalities may precede the onset of illness, and that schizophrenia is not a 
neurodegenerative disorder (Frith, 1992).  Despite these findings, there is much overlap 
with normal subjects, which cautions against using the size of these brain structures 
alone as “markers” for schizophrenia (Frith, 1992).  In summary, dopamine appears to 
have a role in psychosis, though its precise mechanism remains uncertain.  Enlarged 
ventricles appear to be a feature of psychosis and may be present before the onset of the 
illness.
1.1.5  Psychological model of psychosis 
It is now widely accepted that psychotic disorders are a heterogeneous group of 
disorders that lie on a continuum with normality (Fowler, Garety, & Kuipers, 1995). 
Psychological therapies, in particular Cognitive Behavioural Therapy (CBT), are 
becoming increasingly recognised as an effective part of treatment for psychosis. 
Cognitive theories of psychosis have mainly been drawn from Beck’s theory of
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emotional disorders (Beck, 1976).  As in the case of emotional disorders, individuals 
with psychosis frequently present to therapy because they are in distress.  CBT focuses 
on the underlying thoughts, beliefs and behaviours that are causing and maintaining this 
distress (Nelson, 2005).  To illustrate a CBT model of psychosis, I shall focus on 
Freeman and Garety’s model of delusions (2004).
A delusion may be defined as a strongly held belief not subject to reason or 
contradictory evidence and not explained by a person’s usual cultural concepts (Freeman 
& Garety, 2004).  In a CBT model, the origins of delusions are broadly viewed within a 
stress vulnerability framework (Freeman & Garety, 2004).  It is hypothesised that a 
stressor precipitates the formation of a delusion, and this stressor causes arousal usually 
in the form of anxiety (Freeman, Garety, Kuipers, Fowler, & Bebbington, 2002).  In 
individuals vulnerable to developing psychosis, this arousal may be experienced as an 
internal anomalous experience causing ideas of reference, depersonalisation and 
perceptual abnormalities.  These anomalous internal experiences initiate a search for 
meaning, which is a critical point in the development of psychosis.  The individual’s 
core beliefs and any potentially significant information from the external environment 
may be drawn into the search for meaning, irrespective of whether the information is 
positive, negative, neutral or ambiguous (Freeman & Garety, 2004).  Several cognitive 
biases are thought to contribute to the formation of a delusion.  Studies have shown that 
many individuals with psychosis tend to seek less information in their decision-making 
and therefore ‘jump to conclusions’ (Garety, Hemsley, Wessely, 1991).  Another 
cognitive bias common in delusions is ‘personalisation’, whereby the individual attaches 
personal significance to external events.  Poor flexibility in considering alternative
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explanations may also promote delusion formation (Garety et al., 1997).  The interplay 
between cognitive processes and external events results in the formation of a delusion, 
the strength of conviction of which depends on the success of maintaining processes.
Delusions are maintained by a number of cognitive and behavioural processes. 
The individual may experience negative reinforcement when a delusion is formed that is 
consistent with pre-existing beliefs and explains an internal anomolous experience. 
Cognitive biases maintain persecutory delusions by obtaining confirmatory evidence 
consistent with pre-existing beliefs and ignoring disconfirmatory evidence.  High levels 
of anxiety relating to the delusion may promote the use of safety behaviours that in turn 
prevent the individual from being exposed to disconfirmatory evidence (Freeman & 
Garety, 2004).  When disconfirmatory evidence is experienced, it may be incorporated 
into the delusion system whereby it is believed that characteristics of the perpetrator and 
the situation prevented the occurrence of harm (Freeman & Garety, 2004).  Threat 
related memory biases might aid recall of evidence thus supporting future appraisals 
(Freeman & Garety, 2004).  The individual’s behaviour towards others (e.g. hostility, 
withdrawal) may reinforce their delusions as others may withdraw, become hostile or 
stigmatise the individual.  Social isolation may also maintain a delusion whereby the 
individual is unable to modify their thoughts based on communication with others 
(Freeman et al., 2002).
1.1.6  Summary
Psychosis was first documented in the literature over a hundred years ago. 
Although our understanding of psychosis has come a long way since then, the exact
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cause(s) remain uncertain.  Individuals with psychosis are highly represented in mental 
health services, at a large cost to the health service.  Psychological therapies are 
becoming increasingly recognised as an important part of treatment in psychosis.
Genetic predisposition and neurological abnormalities may be linked to the development 
of psychosis, while high expressed emotion in families may be implicated in the relapse 
of psychosis.  Research has increasingly focused on the first episode of psychosis to help 
address the gaps in our understanding of this illness.
1.2.1  First episode psychosis (FEP)
There is much evidence to suggest that the early detection and treatment of 
psychosis results in rapid remission of the condition, better long-term outcomes for the 
individual and lower treatment costs (Birchwood et al., 1992; McGorry & Edwards,
1997).  Before psychosis emerges, patients may experience prodromal symptoms 
(Aitchison, Meehan, & Murray, 1999).  The prodromal phase may be described as the 
period from the first noticeable symptoms to the onset of actual psychotic symptoms 
(Beiser, Erikson, Fleming, & Iacono, 1993).  These may include changed behaviours 
(e.g. social withdrawal, deterioration in social functioning, paranoia), changes in mood 
(e.g. mood swings, depression, anxiety), changes in cognition (e.g. odd or unusual ideas, 
difficulty concentrating) and somatic changes (e.g. loss of appetite and energy, reduced 
motivation) (Yung & McGorry, 1996).
Birchwood, McGorry and Jackson (1997) suggest that the early phase of 
psychosis is formative and predictive of long-term outcome.  Prospective studies have 
shown that a substantial degree of social, psychological and biological deterioration 
occurs in the first two years after presentation, and then plateaus (Birchwood, Todd, &
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Jackson, 1998).  A research group in New York noted that patients with positive 
psychotic symptoms who went for long periods without antipsychotic medication had a 
slower and less complete recovery, and an increased risk of subsequent relapse, than 
those who received prompt treatment (Loebel et al., 1992).  In a study in the UK, the 
delay of treatment was greater than a year in about one quarter of patients, and was 
associated with increasing complications such as life-threatening behaviour and family 
difficulties (Johnstone, Crow, Johnson, & Macmillan, 1986).  Patients who took longer 
than a year to access services showed a three-fold increase in relapse rate over the 
following two years compared with those with a briefer duration of untreated psychosis. 
Intervention after the plateau may be less successful than intervention earlier in the first 
episode.  A review of the literature by Wyatt (1991) led to the conclusion that a delay in 
treating psychosis may lead to biological toxicity.  Relapse, treatment resistance, and 
episodes of untreated psychosis following first treatment may also contribute to this 
proposed toxicity (Birchwood, McGorry, & Jackson, 1997).
1.2.2  Factors which delay treatment in FEP
Research groups in the USA (Loebel et al., 1992), Canada (Beiser et al., 1993), 
Australia (McGorry, Edwards, Mihalopoulos, Harrigan, & Jackson, 1996) and Germany 
(Hafher, Maurer, Loffler, & Riecher-Rossler, 1993) have reported treatment delays of an 
average of one year between onset of psychotic symptoms and the initiation of 
appropriate treatment.  There are many factors which delay FEP patients’ treatment for 
psychosis.  The first clinical presentation of psychosis differs greatly between patients, 
which may make diagnosis difficult and delay early detection.  FEP commonly occurs in 
adolescence or early adulthood, and the signs and symptoms that occur may be
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attributed to adolescent problems such as the stress of school or work and relationship 
difficulties.  In many cultures there is stigma associated with mental illness, which may 
pose a barrier to seeking help.  Some of the signs and symptoms that are displayed in the 
first episode may be similar to physical illnesses such as temporal lobe epilepsy, cerebral 
infection or trauma, and metabolic disorders (Aitchison et al., 1999).  Alternatively, 
psychotic symptoms may be superimposed on pre-existing mental health problems such 
as personality disorder.  Both prescribed and illicit drugs may also produce the kind of 
symptomatology reported in psychosis.  In summary, the heterogeneous presentation of 
psychosis, age of onset, stigma and incorrect diagnosis by health professionals may 
delay treatment in FEP.  Educating the community and health care professionals about 
psychosis may help to alleviate some of the barriers to treatment.
1.2.3  Services for FEP
Early intervention services (EIS) emerged from the need to treat young people in 
a user friendly way at the earliest possible stage after the onset of psychosis.  Their aim 
is to provide a comprehensive and integrated hospital and community service with 
continued care throughout the critical period (2 years following entry into the 
programme) with the aim of reducing secondary morbidity (McGorry & Edwards,
1997).  There is evidence that patients who received care from EIS had shorter durations 
of untreated psychosis, reduced inpatient treatment, reduced neuroleptic use, 
improvement in negative symptoms and better psychosocial functioning (McGorry & 
Edwards, 1997).  In Australia the Early Psychosis Prevention and Intervention Centre 
(EPPIC) was shown to be cheaper and more cost effective than the pre-EPPIC system 
(McGorry & Edwards, 1997).
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The first episode patient's initial experience of mental health services may predict 
future treatment compliance and help-seeking in the event of relapse (McGorry & 
Edwards, 1997).  EISs need to cater to the needs of their client group, many of whom are 
in their teenage years, to make the service as attractive as possible to them.  Some ways 
of catering to this client group might include adopting a more informal dress code 
among staff, meeting clients in places outside of the service such as cafes, keeping in 
touch with them via text messaging and decorating the service in a contemporary way. 
Those affected by FEP are often at an age where they may be concerned about how they 
appear to their peers.  Aitchison, Meehan, and Murray (1999) recommend that treatment 
should maximise therapeutic benefit while minimising side-effects (e.g. tremors, tardive 
dyskinesia).  The focus of care should be the re-integration of the patient back into their 
community with monitoring by services to prevent relapse (Aitchison et al., 1999). 
Psychological treatment should also be part of both the initial treatment package and 
continuing care (Drury, Birchwood, Cochrane, & Macmillan, 1996).
1.2.4  Cognition in FEP
Research suggests that cognitive difficulties have important implications for 
outcome in psychotic patients (Green, 1996).  This is especially pertinent for those 
experiencing their first psychotic episode, which often occurs when post-secondary 
studies or occupational endeavours are a major concern (Townsend, Norman, Malla, 
Rychlo, & Ahmed, 2002).  Advances in the development of antipsychotic medications 
have improved symptom reduction. However, the role of cognitive deficits in the 
aetiology of schizophrenia has received much less attention to date.  There has been 
much debate in the literature regarding the nature, severity, and timing of onset of
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cognitive deficits as well as the course they take.  Some researchers have found evidence 
that cognitive deficits may pre-date the emergence of psychosis.  Those at high risk of 
developing psychosis have been shown to have compromised cognitive performance on 
complex tasks involving visuospatial processing and memory (Brewer et al., 2005; 
Johnstone, Ebmeier, Miller, Owens, & Lawrie, 2005) and attention (Johnstone, Ebmeier, 
Miller, Owens, & Lawrie, 2005) before the full emergence of psychotic illness.  An 
understanding of the neuropsychological deficits associated with FEP could have 
important clinical applications in the future, as these deficits may influence patients’ 
recovery.  Interventions aimed at reducing the impact of these deficits may reduce the 
long term social consequences of psychosis for individuals.
1.2.5  Summary
Early intervention services have arisen from the need to treat FEP at the earliest 
opportunity to improve treatment outcome and lower treatment costs.  Cognitive 
function may play a pivotal role in outcome and recovery, though this area has received 
relatively little attention to date.  A better understanding of the nature and extent of 
cognitive deficits in FEP is needed, as this area may have important treatment 
implications in the future.
1.2.6  Aims of the review
This aims of this review are to examine the research evidence for cognitive 




Relevant studies of patients with first-episode psychosis were identified using a 
three-stage search strategy.  Firstly, multiple computer searches of the databases 
CINAHL, PsycINFO, Medline, Web of Science, Francis, Trip, the Cochrane library and 
Science direct were conducted between July and December 2006 utilising the full date 
ranges of publication available for the databases.  The following keywords were used to 
search across titles “cognitive with deficit* or dysfunction* or impairment*” and “first 
episode with psychosis or schizophrenia”.  Secondly, relevant journals (e.g. 
Schizophrenia Research, Psychopathology) were hand searched from the past 5 years 
(2001-2006).  Thirdly, the reference sections of key papers were examined in order to 
identify further relevant papers.
3. Results
One hundred and thirteen papers were identified using this search strategy (98 
from databases, 15 from hand-search).  Of these, 87 were excluded because they were 
either not published in English or were concerned with pharmacotherapy, early 
intervention service development, expressed emotion in relatives, bipolar disorder, 
childbirth induced psychosis, insight in psychosis, crisis intervention, alcohol and 
substance abuse, duration of untreated psychosis and outcomes, non compliance with 
medication, service users perspectives and/or the prodromal phase of schizophrenia. 
Twenty-six were included in the review (16 from the database and 10 from the hand 
search).  The included papers were then categorised according to their subject area.
These were neurological (6), cognitive deficits (15), and social functioning (5).  Each set 
of papers will be reviewed in turn in the sections below.
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3.1  Neurological
The neurological papers were mainly concerned with the presence of 
neurological soft signs (NSS) and brain morphology.
3.1.1  Neurological soft signs
The presence of NSS in FEP is widely reported; however, there is some 
difference of opinion regarding what form these signs take.  Dazzan and Murray (2002) 
conducted a systematic review of 9 studies that examined NSS at the time of first 
presentation in FEP or schizophrenia and compared them with healthy controls or those 
at high-risk of developing psychosis.  The authors found that first episode patients 
showed an excess of NSS especially in the areas of motor coordination and sequencing, 
sensory integration and reflexes.  A limitation noted in the review was the relatively 
small number of studies that have examined NSS in FEP.  Also, the variety of 
instruments used to assess NSS made it difficult to compare results (Dazzan & Murray, 
2002).
Since NSS appear to be present at the beginning of the psychotic illness, some 
authors have examined the stability of these signs over time.  Bachmann, Bottmer, 
Weimer, and Schroder (2003) conducted a follow-up study of 39 first episode 
schizophrenia patients at 14.2 months after treatment for schizophrenia or 
schizophreniform disorder.  At follow-up, NSS as assessed by the Heidelberg scale 
(Schroder et al., 1992) had decreased significantly.  The authors concluded that NSS are 
a state related variable.
Some researchers have examined whether NSS are associated with cognitive 
impairments.  Schuepbach, Sanders, and Keshavan (2002) assessed 59 neuroleptic naive
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first episode patients and 51 matched healthy controls using a modified neurological 
evaluation scale (NES) (Buchanan & Heinrichs, 1989), clinical ratings and a 
neuropsychological battery.  Those with FEP showed more NSS and decreased 
performance in neurocognition.  The cognitive perceptual domain of NES predicted 
specific neuropsychological functions measuring attention, language skills and executive 
functioning.  The authors concluded that parts of the NES (e.g. cognitive perceptual 
domain) can reliably predict prefrontally mediated cognitive dysfunction in first episode 
schizophrenia.  A potential criticism of this study is that the NES does not have a 
“cognitive perceptual” subscale, and it was unclear from the article how the authors had 
calculated this.  However, their finding that patients with FEP showed an excess of NSS 
was consistent with Dazzan and Murray’s (2002) findings as discussed above.
It appears that first episode patients show an excess of NSS in comparison to 
healthy controls and those at high-risk of developing psychosis (Dazzan & Murray,
2002; Schuepbach et al., 2002). NSS in FEP decrease over time (Bachmann et al., 2003) 
and may be related to prefrontally mediated cognitive dysfunction (Schuepbach et al., 
2002).
3.1.2  Brain morphology 
Some researchers have investigated whether there are differences in the 
underlying brain morphology of first episode patients compared with normal subjects. 
Steen, Mull, McClure, Hamer, and Lieberman (2006) conducted a systematic review and 
meta-analysis of Magnetic Resonance Imaging (MRI) studies comparing brain volume 
in FEP patients and healthy controls. They included 66 papers in their analyses and 
found that whole brain and hippocampal volume were reduced and ventricular volume
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was increased in first episode patients relative to healthy controls.  A potential limitation 
of the studies reviewed was their small sample size and a lack of replication where 
particular significant effects were found.  In addition to this, few environmental factors 
(e.g. medication, alcoholism and social deprivation) were controlled for in the studies 
reviewed, and it is possible that these factors may have contributed to the morphological 
changes observed.
Similar findings were reported in a study by Vita, De Peri, Silenzi, and Dieci 
(2006).  They conducted a meta-analysis of quantitative MRI studies in first episode 
schizophrenia.  They included 21 studies and found significant overall effect sizes for 
lateral and third ventricular volume increase, and for volume reduction of whole brain 
and hippocampus relative to healthy controls.  The authors concluded that brain 
abnormalities are present at the early stages of psychosis.
To see whether morphological differences were stable over time, Lieberman et 
al. (2001) conducted a longitudinal study in first episode schizophrenia.  They compared 
first episode schizophrenia (n=107) and healthy controls (n=20) on MRI, clinical 
assessments of psychopathology, and treatment outcome for up to 6 years.  The authors 
found ventricular enlargement and anterior hippocampal volume reductions in first 
episode schizophrenia relative to healthy controls.  In addition to this, patients who were 
classified as having poor outcome schizophrenia (failure to respond to treatment and 
reoccurrence of persistent positive and negative symptoms) showed total ventricular 
enlargement over time compared with good outcome patients.  This finding contrasts 
with the assumption mentioned earlier in this review that the ventricles in patients with 
schizophrenia do not enlarge over time (Gattaz et al., 1991).  A possible limitation of 
this study was the small number of control participants used.  Also, the average age of
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the control group was significantly higher than the first episode schizophrenia group.  As 
the brain changes structurally over time (Droge & Schipper, 2007), the control group 
may not have provided an accurate comparison for the first episode schizophrenia group 
There appears to be consistent findings in the studies reviewed regarding the 
brain morphology of first episode patients.  Whole brain and hippocampal volume were 
reduced and ventricular volume was increased in FEP (Lieberman et al, 2001; Steen et 
al., 2006; Vita et al., 2006) relative to healthy controls.  Those who did not respond well 
to treatment and had persistent symptoms showed ventricular enlargement over time 
(Lieberman et al., 2001).  This suggests that the brains of those who do not respond well 
to treatment may be subject to neurodegeneration over time.  However, this 
interpretation is tentative as it is based on the results of only one study.
3.2  Cognitive deficits
As FEP patients show an excess of NSS and differences in brain morphology 
compared to healthy controls it is plausible that there may be some resulting cognitive 
dysfunction.  This will be explored in the next section of the review.  Due to the large 
number of cognitive papers, they were divided into the following categories: generalised 
deficits, specific deficits, subjective experiences, course, symptoms, and treatment.
3.2.1  Generalised deficits 
There is much literature regarding the general profile of cognitive deficits in 
FEP.  Addington, Brooks, and Addington (2003) looked at FEP compared with healthy 
controls by assessing a large sample (n= 312) of first episode patients who had no more 
than 3 months of previous treatment.  First episode participants scored lower than
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controls on all tests administered.  They demonstrated particular difficulty in verbal 
fluency, verbal memory, and working memory.  They also scored poorly on measures of 
attention, information processing, and motor skills.  These deficits have some similarity 
to the deficits in executive function, memory, attention and motor skills found in 
schizophrenia generally (Green, 1998). There were no associations between cognition 
and positive symptoms and a range of associations between negative symptoms and 
cognition.  These findings are commonly found in schizophrenia generally (Green,
1998).
Mohamed, Paulsen, O'Leary, Arndt, and Andreasen, (1999) found a similar 
pattern of deficits in their study which looked at 94 recently admitted first episode 
patients and 305 healthy controls.  They used a comprehensive battery of tests that 
assessed the domains of psychomotor speed, executive function, memory, and problem 
solving.  Those patients with first episode schizophrenia showed impairments on most 
measures relative to controls, and the authors concluded that first episode patients have a 
generalised deficit in cognitive function.
In summary, there appear to be consistent findings from the literature to support 
evidence for a generalised cognitive deficit in FEP.  First episode patients were impaired 
relative to controls on most areas of cognition including verbal fluency, verbal memory, 
working memory, attention, processing skills, and motor skills (Addington et al., 2003; 
Mohamed et al., 1999).  Negative symptoms were associated with cognition (Addington 
et al., 2003).  These findings reflect the literature on psychosis more generally (Green,
1998).
3.2.2  Specific deficits
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Since there is much research evidence to support the presence of cognitive 
deficits in FEP, some researchers have queried whether there may be more specific 
rather than generalised deficits.  Barrett, Mulholland, Cooper, and Rushe (2006) 
compared first episode schizophrenia patients and healthy controls on a range of 
neuropsychological assessments.  They divided the patient group into a poor 
organisation and strategy (OS) group and a good OS group.  Poor OS patients had higher 
levels of depressive symptoms.  They were also more impaired on tests of semantic 
fluency, verbal memory, attention, working memory and executive function compared to 
good OS patients and controls.  The authors concluded that a high percentage of patients 
demonstrated a clear fronto-parietal deficit, which may reflect a disruption of normal 
brain maturational processes in adolescence.  However, the mean age of their sample 
(30.8 years, ±11.7) was not representative of the adolescent age group, which may not 
offer sufficient support for their conclusion.  Also, it is possible that the depression 
experienced by the poor OS patients may have interfered with their performance on the 
neuropsychological assessments.  Nevertheless, their results suggested that there were 
two sub-groups within the sample of patients, one of which was significantly more 
impaired than the other in neuropsychological function and had higher levels of 
depressive symptoms.
Fagerlund, Pagsberg, and Hemmingsen (2006) examined cognitive deficits and 
levels of IQ in adolescent onset schizophrenia and other psychotic disorders.  They 
assessed 39 first episode adolescents (18 diagnosed with first episode schizophrenia, 21 
with non-organic non-affective psychoses), and a matched healthy control group.  A 
range of neuropsychological tasks was used which assessed IQ, attention, executive 
function, reaction time and memory.  A similar profile and level of impairment were
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found on measures of attention, executive function, reaction time, and memory across 
the first episode schizophrenia and non-organic non-affective psychoses groups in 
comparison to controls.  However, the first episode schizophrenia group had more global 
IQ deficits than those with non-organic non-affective psychoses.  Declines in levels of 
IQ from pre-morbid functioning have been reported generally in studies of schizophrenia 
(Weickert et al., 2000), and the authors proposed that the illness might have a negative 
impact on IQ because none of the participants were reported to have learning difficulties 
prior to illness onset.  A measure of pre-morbid IQ would have clarified this issue.
Some studies have looked at olfactory deficits as a predictor of the severity of 
symptoms, because olfactory deficits are thought to be a marker of orbito-frontal 
function.  Brewer et al. (1998) compared healthy controls (n=24), patients at high risk 
for psychosis (n=65), never medicated FEP patients (n=49) and medicated FEP (n=25) 
patients.  The high risk group and both patient groups demonstrated significant 
reductions in current IQ, smell identification as measured by the University of 
Pennsylvania Smell Identification Test (UPSIT) (Doty, Shaman, & Dann, 1984), 
attention, memory and executive function compared to controls.  Over the 18 month 
recruitment phase 32% of the high risk patients became psychotic.  The authors 
concluded that reductions in IQ and deficits in smell identification, attention, memory 
and executive function are present at the outset of psychosis and are not due to 
medication effects.
Good, Whitehom, Rui, Milliken, and Kopala (2006) used the UPSIT to assess 58 
medication naive FEP patients at baseline and at 1  year.  Patients with non-remission of 
negative and cognitive/disorganized symptoms had significantly lower baseline UPSIT 
scores compared with patients in remission.  The authors did not suggest a possible
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mechanism for this and concluded that UPSIT scores could be used to identify patients 
at risk for persistent negative and cognitive/disorganised symptoms.  It is plausible that 
the orbito-frontal area of the brain, which is responsible for smell, may also be 
associated with negative and cognitive/disorganized symptoms in FEP.
In summary, some authors have reported more specific deficits in IQ among 
those patients at high risk of developing psychosis (Brewer et al., 1998)  and those with 
FEP compared with patients with non-organic non-affective psychosis (Fagerlund et al., 
2006).  Some authors have identified sub-groups of FEP patients who are more impaired 
in attention, working memory, semantic fluency, verbal memory, and executive function 
and have higher levels of depressive symptoms (Barrett et al., 2006).  Smell 
identification, which is understood to reflect orbito-frontal function, may be impaired 
from the outset of the illness and may be used to predict those at risk of more persistent 
symptoms (Brewer at al., 1998; Good et al., 2006).  However, as few studies have been 
conducted in this area any conclusions drawn from the literature must be tentative.
3.2.3  Subjective experiences of cognitive dysfunction 
There appears to be much objective evidence regarding the presence of cognitive 
deficits in FEP, and some authors have questioned whether first episode patients are 
aware of these.  Moritz et al. (2001) used the Frankfurt Complaint Questionnaire (FCQ) 
(Stilwood, 1986) to assess subjective cognitive dysfunction in 20 first episode patients, 
36 patients with chronic schizophrenia and 20 healthy controls.  Ratings were 
comparable for each schizophrenia group and were significantly higher than for healthy 
controls.  The authors concluded that since both groups had equal awareness of their 
deficits, cognitive functions do not deteriorate further after the first episode of psychosis.
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One criticism of this study is that the FCQ has been shown to have poor diagnostic 
validity and reliability compared to the Eppendorf Schizophrenia Inventory (ESI) (Mass,
2000), which may have been a more appropriate measure to use (Mass, 2005).
Moritz et al. (2000) investigated the relationship between subjective cognitive 
disturbances and symptomatic outcome.  Fifty-three FEP patients were assessed at 
baseline, and 31 were followed up 1  year later.  The FCQ and the Brief Psychiatric 
Rating Scale (BPRS) (Ventura, Green, Shaner, & Liberman, 1993) were used, the latter 
to assess symptoms.  Awareness of memory dysfunction was the strongest predictor of 
symptomatic worsening.  However, the authors did not suggest a mechanism to account 
for this relationship.  The authors concluded that memory dysfunction may be a 
potential risk factor for symptom worsening and suggested that first episode patients 
may benefit from cognitive rehabilitation to remedy this deficit.  Some potential 
weaknesses of this study were that objective neuropsychological tests were not used to 
explore the self-reported memory dysfunction, and the authors did not suggest a 
mechanism whereby memory and symptoms were linked.
3.2.4  Course of cognitive deficits 
Several studies have looked at the stability of cognitive deficits over the course 
of psychosis.  Addington and Addington (2000) looked at initial presentation and 
follow-up at 1  and 2 years in first episode patients.  Ninety subjects were followed up at 
1  year and 47 subjects at 2 years.  Poor neurocognitive performance was associated with 
negative symptoms rather than positive symptoms at both follow-ups.  There was a trend 
towards general improvement in neurocognition and a significant improvement on some 
memory tasks in both periods; however, performance remained in the impaired range.
29Review Paper
The authors did not report whether or not the participants were taking medication, which 
may have impacted on the results.
Addington, Saeedi, and Addington (2005) later conducted a 3 year longitudinal 
study of247 first episode patients compared with non-psychiatric controls.  They 
assessed cognition at baseline, 1  year (n=154) and 2 year follow-up (n=124).  They 
found that positive symptoms improved significantly from baseline to 1  year.  There was 
significant improvement over time in several neurocognitive domains including 
executive function, psychomotor speed, response inhibition and verbal memory.  One 
potential weaknesses of this study was that all participants showed improvement over 
the course of the study, perhaps due to learning effects because there were no alternate 
forms of the tests used. Again, the authors did not report whether or not the participants 
were medicated, which may have impacted on the results.
It is difficult to draw any firm conclusions from the research on the course of 
cognitive deficits in FEP because there have been few studies in this area, and those 
studies that have been conducted exhibit weaknesses in design.  Both studies reviewed 
suggested some improvement in cognitive function (Addington & Addington, 2000; 
Addington et al., 2005); however, this improvement remains in the impaired range 
(Addington & Addington, 2000).  This fits with Moritz et al.’s (2001) finding that 
cognitive deficits do not deteriorate further after the first episode.  In one study poor 
neurocognitive performance was associated with negative symptoms rather than positive 
symptoms (Addington & Addington, 2000).  This is consistent with Addington et al.’s
(2003)  finding earlier in the review that negative symptoms were associated with 
cognition. The contribution of symptoms to cognitive function will be examined further 
in the next section.
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3.2.5  Symptoms
Some researchers have specifically examined the relation between psychotic 
symptoms and cognitive function in first episode patients.  Prikryl et al. (2003) looked at 
the association between severity of psychotic symptoms as measured by the Positive and 
Negative Syndrome Scale (PANSS) (Kay, Fiszbein, & Opler, 1987) and performance on 
the Wisconsin Card Sorting Test (WCST).  The PANSS was administered before and 28 
days after treatment with anti-psychotic medication.  There were significant reductions 
in PANSS ratings after treatment, but PANSS scores were not correlated with WCST 
scores.  The authors concluded that symptoms may not be related to cognitive function 
in FEP.
Addington and Addington (1998) also looked at the relation between psychotic 
symptoms and cognitive function.  They compared first episode patients who were 
recently diagnosed with schizophrenia or schizophreniform disorder with a sample of 
patients who had been ill for many years with a diagnosis of schizophrenia. The first 
episode group had more positive symptoms, while the patients who had been ill for 
longer had more negative symptoms.  Those who had been ill for longer scored more 
poorly on the WCST and tests of memory than first episode patients.  The authors 
concluded that neurocognitive function was more related to negative than positive 
symptoms, which is consistent with Addington and Addington’s (2000) finding. 
Addington and Addington (1998) also found that memory and executive function may 
deteriorate after the first episode.  This is in contrast to findings reported earlier in the 
review that cognitive function may not deteriorate further after the first episode 
(Addington & Addington, 2000; Addington et al., 2005; Mortiz et al., 2001).
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The evidence regarding the relationship between symptoms and cognitive 
deficits is inconclusive.  Prikryl et al. (2003) found no association, while Addington and 
Addington found that cognitive function was more related to negative than positive 
symptoms in two separate studies (1998; 2000).  From the three studies reviewed it 
appears that cognitive function may be related to negative symptoms.  However, further 
research in this area is needed in order to draw more definitive conclusions.
3.2.6  Treatment effects
Some studies have looked at the effectiveness of pharmacological treatment and 
cognitive dysfunction in FEP.  Harvey, Rabinowitz, Eerdekens and Davidson (2005) 
compared the effectiveness of Haloperidol and Risperidone in 533 patients experiencing 
their first episode of schizophrenia or a related psychosis.  Those treated with 
Risperidone showed wide-ranging improvements in cognitive function.  Overall 
improvement was greater with Risperidone than Haloperidol.
Keefe (2004) conducted a more extensive study comparing the cognitive effects 
of low doses of atypical and typical antipsychotic medication.  In the first part of the 
study, 167 first episode patients were randomized to 2 years of double-blind treatment 
with Olanzapine or Haloperidol and were given neuropsychological assessments at 
baseline, 12 weeks, 6 months, 12 months and 2 years after treatment.  Both drugs 
improved cognitive function; however, Olanzapine had a greater effect.  In the second 
part of the study, low doses of Haloperidol were compared with Risperidone.  Patients in 
each group demonstrated significant improvement; however, Risperidone patients 
demonstrated greater improvement.  The authors concluded that atypical antipsychotics
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are superior at improving cognition, which is consistent with the findings of Harvey et 
al. (2005).
Schuepbach, Keshavan, Kmiec, and Sweeney (2002) found no advantage in 
using Risperidone over Haloperidol in their study of 34 first episode patients.  Twenty- 
three patients were treated with Risperidone and 16 with Haloperidol.  The scale for 
Assessment of Negative Symptoms (SANS) (Andreasen, 1983) and the Scale for 
Assessment of Positive Symptoms (SAPS) (Andreasen, 1984) were used to assess 
symptoms.  Although anti-psychotic medication markedly reduced clinical 
symptomatology, there was no clinical advantage in using Risperidone over Haloperidol. 
In contrast to Keefe’s (2004) study a smaller sample was used and there was a shorter 
follow-up period after medication.  Therefore, Keefe’s (2004) study may be more 
informative.
It seems that Risperidone and Olanzapine may improve cognitive deficits in FEP 
more than Haloperidol (Harvey et al., 2005; Keefe, 2004).
3.2.7  Summary
There appears to be clear evidence to support a generalised cognitive deficit in 
FEP, which is also reported in the psychosis literature more generally.  There may be a 
sub-group of FEP participants who are more impaired in some aspects of cognitive 
function and IQ, and show higher levels of depression.  Depression may affect 
performance on neuropsychological tasks, and this relationship should be explored 
further in future studies.  Subjective awareness of memory dysfunction may predict 
symptomatic worsening.  Awareness of cognitive dysfunction does not appear to differ 
between first episode and multi-episode groups.  This area of research would benefit
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from employing objective neuropsychological tests alongside subjective measures of 
cognitive dysfunction.  It seems that cognitive dysfunction may improve over the course 
of the illness; however, functioning may remain in the impaired range and may be 
related to negative symptoms.  In terms of pharmacological treatment, atypical 
antipsychotics (e.g. Risperidone and Olanzapine) may be more effective than 
Haloperidol in treating cognitive deficits in FEP.
The final part of the review will examine the relationship between cognitive and 
social functioning in FEP.  The cognitive deficits found in FEP may have a significant 
impact on many of these skills and the quality of life of these individuals.
3.3  Social functioning
The term “social functioning” refers to skills and competencies in a number of 
different areas including community and occupational functioning, employment, and 
activities of independent living and self-care.  There are few studies on social 
functioning in FEP, which was reflected in the search results.  The papers reviewed were 
divided into the following areas: cognition and social functioning; first and multi­
episode psychosis; and social anxiety.
3.3.1  Cognition and social functioning
Some studies have looked at the influence of cognitive deficits on social and 
community functioning in FEP, with mixed results.  Addington and Addington (2004) 
assessed cognition and social outcome in 182 first episode patients and 127 of these at a 
2 year follow-up.  The authors did not specify the outcome measures used to assess these
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variables.  They found a few statistically but not clinically significant improvements at 2 
years.  After controlling for symptoms, regression analyses showed that cognitive 
impairment accounted for only 4-6% of the variance in social functioning.  The authors 
concluded that although related, poor social functioning may be independent of 
cognitive function in FEP.
In a separate study, Addington and Addington (2005) conducted a prospective 
cohort study of 194 people with FEP.  They assessed pre-morbid functioning using the 
Pre-morbid Assessment Scale (PAS) (Cannon-Spoor, Potkin, & Wyatt, 1982), symptoms 
using the PANSS, and social functioning using the Quality of Life Scale (QOL) 
(Burckhardt &  Anderson, 2003).  Data was collected at baseline, 1  and 2 years.  The 
authors identified 4 patterns of pre-morbid functioning: deteriorating, stable- 
deteriorating, stable-good, and stable-intermediate.  They found that at both 1  and 2 
years, participants with a deteriorating or stable-deteriorating pattern of pre-morbid 
function had more severe negative symptoms and more impaired social functioning than 
those with stable-good and stable-intermediate patterns of pre-morbid function.  The 
authors concluded that poor pre-morbid functioning prior to diagnosis may predict poor 
social and symptomatic outcome in FEP.
Verdoux, Liraud, Assens, Abalan, and Van-Os (2002) did a follow-up study of 
cognitive and social functioning in FEP to examine whether baseline memory and 
executive function deficits predicted poor social and clinical outcome over a 2 year 
period following first admission.  Cognitive function was assessed in 35 patients 
admitted with FEP.  The cognitive tests assessed the domains of executive function, 
response inhibition, psychomotor speed, attention, and verbal and visual memory. 
Patients were assessed at 6 monthly intervals over the 2 year follow-up.  Social outcome
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was assessed by occupational and residential status, whereas clinical outcome was 
assessed by re-hospitalisation data and symptomatic status.  The authors found no 
significant association between cognitive performance and social outcome (either 
occupational or residential), but significant associations were found between poor 
memory scores and worse clinical outcome.  A potential limitation of this study was the 
lack of standardised social functioning and symptomatic measures used.
The studies reviewed show little (Addington & Addington, 2004) or no evidence 
(Verdoux et al., 2002) of an association between cognitive deficits and social 
functioning in FEP.  Pre-morbid function prior to diagnosis may predict social and 
symptomatic outcome in FEP (Addington & Addington, 2005).  A weakness of the 
studies reviewed is a lack of standardised measures used to assess social functioning, 
which may have reduced their ability to detect significant differences (i.e. Type II error).
3.3.2  First and multi-episode (ME) psychosis 
Some authors have compared first episode and multi-episode patients with 
psychosis to see if there are differences in social functioning between the groups.  Grant, 
Addington, Addington, and Konnert (2000) assessed social functioning in 40 patients 
experiencing first episode schizophrenia, 40 individuals who had experienced ME 
schizophrenia, and 40 non-psychiatric controls.  The participants were assessed using the 
Social Functioning Scale (SFS) (Birchwood, Smith, Cochrane, Wetton, and Copestake, 
1990), QOL, the assessment of interpersonal problem solving skills (AIPSS) (Donahue 
et al., 1990) and the PAS.  The control group performed much better on all measures 
than both patient groups.  There were no differences between the two schizophrenia 
groups on the PAS, SFS, and the AIPSS.  On the QOL, first episode participants scored
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more poorly than the multi-episode group.  This result did not fit with their hypothesis 
that first episode patients would have improved social functioning compared to multi­
episode patients.  The authors concluded that social functioning deficits appear to be 
present at the beginning of the illness and do not deteriorate throughout the course of the 
illness.  Although there appears to be little or no relationship between social functioning 
and cognition in FEP, this finding is consistent with research discussed earlier in the 
review, which showed that cognitive deficits do not appear to worsen over time 
(Addington & Addington, 2000; Addington et al., 2005; Moritz et al., 2001).
3.3.3 Social anxiety
Voges and Addington (2005) looked at the association between social anxiety 
and social functioning in FEP.  They assessed 60 FEP patients.  Social phobia was 
assessed using a structured clinical interview for DSM-IV criteria (SCID-I) (Spitzer, 
Williams, Gibbon, & First, 1992).  They also used the Social Phobia and Anxiety 
Inventory (SPAI) (Turner, Bendel, & Dancu, 1996) and the SFS.  They found that 32% 
of the sample met SCID-I criteria for social phobia, and approximately 60% were 
experiencing elevated levels of social anxiety according to the SPAI.  Higher social 
anxiety scores as measured by the SPAI were related to poor social functioning as 
measured by the SFS.  The authors concluded that high levels of social anxiety were 
significant predictors of social functioning in FEP.  A potential weakness of this study 
was the lack of a non-psychiatric control group for comparison to elucidate the extent of 
social phobia and social anxiety in the general population.
3.3.4  Summary of social functioning studies
37Review Paper
The paucity of studies on social functioning in FEP, lack of standardised 
measures to assess social functioning, and absence of control groups makes it difficult to 
draw any firm conclusions from the research in this area.  However, from the studies 
reviewed it seems there is little or no association between cognitive deficits and social 
functioning in FEP.  This contrasts to findings in schizophrenia generally where 
cognitive deficits are associated with social functioning (Green, 1996; Green, Kern, 
Braff, & Mintz, 2000).  Pre-morbid function prior to diagnosis and social anxiety may 
predict social outcome in FEP.  Social functioning does not appear to worsen over the 
course of the illness and difficulties in this area may be present from the outset, but 
clinical experience suggests that some patient’s social functioning deteriorates over the 
course of psychotic illness.
4.  Discussion
This review examined the research evidence for neurological and cognitive 
deficits in FEP and their relation to social functioning.  The studies included in the 
review were broadly categorised into neurological, cognitive deficits and social 
functioning subject areas.  The following section will discuss the main findings of the 
review and compare these findings to the wider literature.
4.1  Neurological
The neurological papers reviewed suggested that individuals with FEP show an 
excess of NSS in comparison to healthy controls (Dazzan & Murray, 2002; Scheupbach 
et al., 2002).  This finding has been reported in the schizophrenia literature more 
generally (Bombin, Arrango, & Buchanan, 2005; Rossi et al., 1990), and there is little
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evidence to suggest that these NSS are related to neuroleptic medication (Bartko, Zador, 
Horvath, & Herezeg, 1988; Rossi et al, 1990).  One study included in this review 
suggested that NSS decrease over time with treatment (Buchmann et al., 2002).  There 
are mixed findings in the wider literature regarding the stability of NSS over time. 
However, there is some evidence to suggest that those who developed psychosis and 
NSS had abnormalities in childhood motor responses, which may reflect early 
disturbances in brain function (Walker & Lewine, 1990).  It was hypothesised that these 
abnormalities remain stable throughout life, emerging as NSS during the onset of 
psychosis and fluctuating over the course of the illness when there are variations in state 
such as symptom exacerbations or exposure to illicit drugs or alcohol (Bombin et al., 
2005).  More longitudinal research is needed in this area tracking the pattern of NSS 
over the course of psychosis.
The studies reviewed reported differences in the brain morphology of first 
episode patients compared with healthy controls.  First episode patients showed reduced 
whole brain and hippocampal volume, ventricular enlargement, increased lateral and 
third ventricle volume and reduced anterior hippocampal volume relative to healthy 
controls (Lieberman et al., 2001; Steen et al., 2006; Vita et al., 2006).  The findings 
regarding ventricular enlargement, third ventricle volume and reduced whole brain 
volume have been reported in the schizophrenia literature generally (Chua & McKenna, 
1995; Narayan et al., 1986; Shelton et al., 1988).  One study reviewed reported that first 
episode schizophrenia patients with poor outcome showed ventricular enlargement over 
time (Lieberman et al., 2001).  Again, ventricular enlargement has been reported in the 
schizophrenia literature more generally, though there are mixed findings regarding its 
relation to outcome (DeLisi, Sakuma, Maurizo, Relja, & Hoff, 2004).
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4.2  Cognitive deficits
The next section of the review looked at the evidence for cognitive deficits in 
FEP.  First episode participants were consistently reported to perform more poorly on 
neuropsychological tasks than healthy controls, especially in the areas of verbal fluency, 
verbal memory, working memory, attention, information processing and motor skills 
(Addington et al., 2003; Mohamed et. al, 1999).  This finding reflects the cognitive 
domains known to be impaired in schizophrenia generally (Gold & Harvey, 1993; Green 
et al., 2000) and supports the idea that cognitive deficits are a core feature of the illness 
(Green et al., 2004).  One study found specific deficits in IQ in first episode patients and 
those at risk of developing psychosis compared to healthy controls and patients with 
non- organic non-affective psychosis (Fagerlund et al., 2006).  In the wider literature the 
average IQ reported for those with psychosis is around 90, and some researchers have 
termed this “a generalised performance deficit” (Frith et al., 1991).  Future studies 
would benefit from exploring premorbid levels of IQ in an effort to establish whether the 
reported differences in IQ between psychosis patients and healthy controls are due to the 
effects of the illness or a generalised IQ deficit that predates the illness.
Some studies reviewed reported that smell identification was impaired from the 
outset of psychotic illness and may be used to predict those at risk of developing 
psychosis and persistent negative and cognitive/disorganised symptoms (Brewer et al., 
1998; Good et al., 2006).  This area requires further research because if these findings 
are supported, those at risk of developing psychosis and these symptoms could receive 
interventions to reduce their progression and impact.  Regarding treatment, Risperidone 
and Olanzapine appear to have superior effects in treating cognitive deficits to 
Haloperidol.
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One study looking at the subjective experiences of cognitive deficits in FEP 
found equal awareness of impairments in first and multi-episode patients (Moritz et al,
2001).  This area of research would benefit from incorporating objective measures of 
cognitive function alongside subjective measures that are reliable and valid.  Awareness 
of memory dysfunction was found to be a predictor of symptomatic worsening in one 
study of first episode patients (Moritz et al., 2000).  The relationship between cognitive 
functioning and psychotic symptoms is widely reported in the literature with negative 
symptoms being especially associated with cognitive impairment (Buchanan et al., 1994; 
Hammer, Katsanis, & Iacono, 1995).
4.3  Social functioning
From the studies reviewed, it seems there is little or no relationship between 
cognition and social functioning in FEP.  This contrasts with the findings from the wider 
schizophrenia literature where neurocognitive functioning has been shown to be closely 
associated with social functioning (Green, 1996; Johnstone, MacMillan, Frith, Benn, & 
Crow, 1990).  One study compared first and multi-episode FEP patients’ social 
functioning and concluded that social functioning does not deteriorate throughout the 
course of the illness (Grant et al., 2000).  This is consistent with Addington and 
Addington’s (2000) finding that social functioning in patients with schizophrenia 
remained stable over a 2 X A year follow-up period.  However, further research is needed 
in this area using longer follow-up periods and standardised measures of social 
functioning.  The contribution of social anxiety (Voges & Addington, 2005) and 
premorbid social functioning (Addington & Addington, 2005) to social functioning
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should be examined as the studies reviewed suggested there may be links between these 
variables.
4.4  Methodological limitations
There were a number of potential weaknesses in the papers reviewed.  Some of 
the systematic reviews and meta-analyses used a small number of papers, which did not 
allow for an extensive review of the subject area concerned.  Also, some of the research 
studies used a small number of experimental and/or control participants, which may 
have reduced their statistical power.  In one study, there was a significant age difference 
between the control and experimental groups, which may have led to inaccurate 
comparisons between the groups.  Some of the social functioning studies did not use 
objective neuropsychological tests or validated measures of social functioning.  A few 
studies used questionnaires that have poor diagnostic validity and reliability.  The 
follow-up periods of some of the studies were rather short at times.  Some studies did 
not report on potential confounding factors such as drug and alcohol use and medication.
There were also some weaknesses in this review and the methodology used.  The 
search criteria may not have been specific enough to target papers on specific areas of 
cognitive function, which may have resulted in some relevant papers being excluded 
from the review.  Because of the high ratio of abstracts to full-length papers and the 
space constraints associated with publication, methodological details were often lacking, 
which made it difficult to assess the quality of the studies.
4.5  Recommendations for future studies
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Future studies would benefit from exploring the relationship between IQ and 
performance on neuropsychological assessments.  A sub-group of the participants 
assessed in Fagerlund et al.’s (2006) study showed global IQ deficits compared to 
healthy controls and a psychiatric control group.  It was not clear whether these 
participants’ pre-morbid IQs were in the low range or if they were impaired as a 
consequence of the illness.  Hence, it is unclear whether the impaired performance of 
first episode patients on a range of neuropsychological tasks was due to pre-morbid 
global IQ deficits or illness.
Due to the relatively few studies on social functioning in FEP, further research in 
this area is needed, considering that social functioning may be important for long-term 
social and occupational outcome and personal well-being.  Studies in this area should 
employ standardised measures which assesses the domains thought to be important to 
social functioning (e.g. physical and psychological well being, work/education, leisure, 
finances, living situation, social relations, etc.).
4.6  Conclusions
In spite of the methodological limitations discussed above, this review has 
established that individuals with FEP show neurological abnormalities and a range of 
cognitive deficits.  The data suggests that cognitive deficits may not be related to social 
functioning in FEP, which contrasts with findings in schizophrenia generally; however, 
this area in particular requires further research.
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Abstract
This study explored the relationship between cognitive and community function in 
patients with first episode psychosis.  Cognitive function was assessed using the ‘Brief 
Cognitive Assessment’ (BCA) and Theory of Mind (ToM) tasks.  The BCA assesses 
verbal memory, attention and executive functioning.  Twenty-four patients from two 
early intervention in psychosis services were recruited to complete the tests that 
comprise the BCA (Trails Making Test, the Hopkins Verbal Learning Test and Verbal 
Fluency).  ToM was assessed by means of the Hints Task, Picture Sequencing Stories 
and ToM Stories.  Community function was assessed using the Multnomah Community 
Ability Scale, which was rated by the participants’ care-coordinators.  A measure of 
symptoms (using the BPRS) and a brief measure of current IQ were also completed.  On 
the BCA only Trails A was significantly impaired relative to norms.  Performance on the 
BCA and the Hints Task were associated with community functioning, and these 
findings provide some support for the notion that the BCA and Hints Task may be useful 
predicators of community functioning.
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1.  Introduction
Many studies have demonstrated neuropsychological deficits in psychosis and a 
continuation of these deficits over the course of the illness (e.g. Gold & Harvey, 1993; 
Green et al., 2004).  There is some evidence that these deficits are related to community 
function (Green, 1996).  Research in first episode psychosis (FEP) may give a clearer 
understanding of the pattern and range of deficits at the beginning of the illness, where 
confounding factors such as medication and hospitalisation are less significant than in 
more chronic patients (McGorry & Edwards, 1997).  Intervening in FEP may reduce the 
long-term social and clinical effects of this illness (McGorry & Edwards, 1997).
1.1  Cognitive Assessment
Several studies have found cognitive deficits in the areas of attention, executive 
function, memory and processing speed in first episode populations (Sweeney, Haas, 
Kelip, & Long, 1991; Hutton et al., 1998; Riley, et al., 2000), which suggests that these 
deficits are present at the beginning of psychotic illness.  Discrepancies in scores 
between the National Adult Reading Test (NART; Nelson, 1982) and Wechsler 
Abbreviated Scale of Intelligence (3rd edition) (WAIS III; Wechsler, 1997) suggest 
declines in IQ following onset of FEP (Townsend, Malla, & Norman, 2001).  Research 
suggests that cognitive difficulties have important implications for social and 
community functioning in psychosis (Green, 1996), though this has been less well 
explored in first episode populations.  This is especially pertinent for those experiencing 
their first psychotic episode at an age where post-secondary studies or occupational 
endeavours are a major concern (Townsend, Norman, Malla, Rychlo, & Ahmed, 2002).
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Despite the established relationship between cognition and functional outcome in 
psychosis, cognitive testing is uncommon in psychiatric outpatient settings (Velligan et 
al, 2004).  This may be because such tests require a high degree of expertise and time 
commitment to be carried out, scored and written up.  In order to make cognitive testing 
more feasible in clinical practice, several researchers have focused their attention on the 
development of brief cognitive assessment batteries for use with individuals with 
schizophrenia.  One such battery, the Brief Cognitive Assessment (BCA; Velligan et al., 
2004), utilises standardised tests that examine a variety of cognitive domains in a limited 
fashion.  Normative data are available for all of the tests in this battery.  The BCA has 
been tested for reliability and validity in an outpatient sample of schizophrenia patients 
in the USA (Velligan et al., 2004).  A ‘global cognitive function score’ (GCFS) can be 
calculated by averaging the z-scores achieved for each of the three subtests that make up 
the BCA.  The GCFS is taken as an index of the general level of cognitive functioning. 
Velligan et al. (2004) found that the GFCS was correlated with social and community 
functioning in their patient sample.  The BCA has yet to be used with FEP patients.  The 
cognitive test data from the BCA may be used to monitor change over time, to evaluate 
the effect of different anti-psychotics on cognitive function and to evaluate whether or 
not cognitive rehabilitation is warranted (Velligan et al., 2004).
1.2  Theory of Mind (ToM)
ToM may be defined as the capacity to infer one’s own and other persons’ 
mental states (thoughts, intentions and beliefs) and to use this capacity to predict and 
understand behaviours (Premack & Woodruff, 1978).  Many studies have confirmed that 
individuals with schizophrenia have ToM deficits (see Brtine, 2005, and Harrington,
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Siegert, & McClure, 2005, for reviews).  There is much debate over whether ToM 
involves a separate ‘module’ of fimctioning or is an aspect of executive functioning.  In 
a study by Brune (2005), he found independent effects of ToM and executive 
functioning in patients with schizophrenia and a closer association between ToM and 
social functioning than between executive ability and social fimctioning.  Based on a 
review of studies, Abu-Akel (2003) proposed that ToM ability depends on working 
memory, executive function and other general cognitive abilities.  These contrasting 
findings in the literature may lead to confusion regarding the identification of those at 
risk of ToM deficits.
There has been some difference of opinion regarding whether ToM is a trait or 
state marker in schizophrenia, and if a state marker, what psychotic symptoms are 
associated with it.  The research evidence to date is weighted towards impaired ToM 
being a state marker, and many studies have tried to elucidate the symptoms associated 
with it.  These findings may have important implications as ToM deficits may be 
treatable via the symptoms associated with them.  Frith and Corcoran (1996) compared 
ToM in patients with schizophrenia and controls and found that those with paranoid 
delusions and negative features of schizophrenia were impaired on questions concerning 
mental states; whereas patients with symptoms of passivity (i.e. delusions of control) 
and those in remission did not differ from controls.  Pickup and Frith (2001) found 
similar results whereby patients with behavioural signs were impaired relative to 
controls on ToM, and remitted patients performed as well as controls.  However, in 
contrast to Frith and Corcoran’s findings they found only weak evidence that a subgroup 
with paranoid symptoms had ToM impairments.  Sarfati and Hardy-Bayle (1999) 
showed that those with thought and speech disorganisation showed a deficit in ToMEmpirical Paper
relative to manic and control participants.  From these studies it can be concluded that 
psychotic symptoms including behavioural signs and speech disorganization are 
associated with impaired ToM in schizophrenia, and those who are asymptomatic do not 
have ToM impairments.  The association between paranoid symptoms and impaired 
ToM in psychosis remains unclear.
ToM has not been studied extensively in first episode populations.  A recent 
study by Inoue et al. (2006) found that those in remission from first episode 
schizophrenia showed impaired ToM relative to controls.  In contrast to the widely held 
opinion that impaired ToM is a state marker and may be associated with specific 
symptoms, the authors concluded that their study may provide evidence that impaired 
ToM is a trait marker in schizophrenia.  It is clear from the paucity of literature on ToM 
in FEP that more research is needed in this area.
There is some evidence to suggest that ToM ability may be implicated in 
community functioning in schizophrenia and may have more predictive value in relation 
to social and interpersonal skills than other cognitive domains such as memory, attention 
and executive functioning (Briine, 2005; Pollice et al., 2002).  More research is needed 
to examine the relationship between cognitive deficits, symptomatology and ToM, and 
their relation to community function in people with a psychotic illness.
1.3  Social and community functioning
An understanding of the neuropsychological deficits associated with FEP could 
have important clinical applications in the future, as these deficits may be associated 
with patients’ ability to function in the community.  The most consistent findings in the 
literature are based on studies of chronic schizophrenia populations where community
63Empirical Paper
functioning was correlated with verbal memory, vigilance and executive fimctioning 
(Green, 1996; Green, Kern, Braff & Mintz, 2000).  There has been only limited evidence 
of associations between symptoms and community functioning (Green, 1996).  Most 
studies have examined patients with long durations of schizophrenia where factors such 
as hospitalisation, medication effects and age may have confounded results on social and 
community functioning measures.  Because of these factors, more recent research has 
focused on those with a first episode of psychosis.
There have been mixed results regarding the contribution of cognitive deficits to 
social and community outcome in FEP.  This may be because of the variety of 
assessment instruments used and the different durations of follow-up.  Milev, Ho, Arndt, 
and Andreasen (2005) conducted a 7-year follow-up of first episode schizophrenia 
patients.  They found that cognition (verbal memory, processing speed, and attention) 
and negative symptoms at baseline were related to subsequent outcome.  However, 
negative symptoms explained more of the variance in outcome than cognition.  Other 
studies did not incorporate a measure of symptomatology into their design.  Fujii and 
Wylie (2003) found that verbal memory explained nearly half of the variance in 
community outcome at approximately 15 years follow-up.  Jaeger and Douglas (1992) 
found a correlation between perseverative errors on an executive function task and social 
adjustment at 18 month follow-up.  In summary, as in the case of chronic schizophrenia 
populations, community function may be related to verbal memory and executive 
functioning in those with FEP.  Symptoms may also contribute to community function, 
which perhaps has been overlooked in the research as evidenced by the small number of 
studies that have incorporated a measure of symptomatology into their design.
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1.4  Conclusion
Despite the existence of widespread cognitive deficits and their association with 
community function in schizophrenia, cognitive assessment is not routinely carried out 
in clinical practice.  Advances in the development of antipsychotic medications have 
improved symptom reduction, while cognitive interventions have received much less 
attention.  A holistic approach to treatment of the cognitive deficits as well as the 
symptoms of psychosis might improve patient care significantly and reduce the long 
term social consequences of psychosis.  Cognitive rehabilitation has been increasingly 
cited as an essential component of comprehensive treatment (Storzbach & Corrigan, 
1996; Kern & Green, 1998).  This is potentially very important with first episode 
populations where cognitive rehabilitation could have a significant impact on the 
person’s quality of life and community function.
1.5  Hypotheses
This study will explore some of the issues described above in more detail.  It was 
predicted that: 1) Patients with FEP will be significantly impaired in their performance 
on the BCA relative to normative data.  This is based on Velligan et al.’s (2004) study 
where patients with schizophrenia were significantly impaired relative to norms on all 
subtests of the BCA;  2) BCA performance will correlate positively with community 
functioning, as measured by the Multnomah Community Ability Scale (MCAS) (Barker, 
Barron, McFarland, & Bigelow, 1994).  Again, this is based on Velligan et al.’s (2004) 
finding that the BCA was positively and moderately correlated with measures of 
functional outcome; 3) In a regression model, the BCA will predict more of the variance 
in community functioning than symptom ratings.  This is consistent with Green (1996)Empirical Paper
who found limited evidence of associations between symptoms and community 
functioning in a review of studies; 4) The BCA will be more closely related to level of 
community function than IQ, as measured by the Wechsler Abbreviated Scale of 
Intelligence (WASI) (Psychological Corporation, 1999).  This is supported by the idea 
that people with schizophrenia are specifically impaired in attention, memory, and 
executive function beyond generalised cognitive impairment (i.e. IQ) (Green, 1996; 
Green et al, 2000); 5) Based on the results of the studies carried out by Pollice et al. 
(2002) and Briine (2005) it is predicted that scores on the ToM tasks will be a significant 
independent predictor of community functioning.
2.  Method
2.1  Subjects
A power calculation (Cohen, 1992) to detect a large effect size with an alpha 
level of .05 using regression analyses with 4 predictors recommended a sample size of 
40.  However, due to recruitment constraints 24 participants were recruited.  The 
participants had a DSM-IV (American Psychiatric Association, 1994) diagnosis or 
schizophrenia or related disorder and were recruited from 2 early intervention services 
(EISs) in London.  All participants were fluent in English (for a full description of the 
inclusion criteria see Appendix 1).  The researcher (AW) met with each care coordinator 
in the services and identified suitable candidates from their caseload.  The care 
coordinators were given a handout outlining the process of referring suitable candidates 
to the study (Appendix 1).  The care coordinators gave the identified patients an 
information leaflet about the study (Appendix 2) and asked for consent for the researcher 
to contact them to answer questions and to arrange a time to meet if interested.
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The EIS’s referral criteria were as follows:  patients must be aged 16-30; a 
resident of the local catchment area; experiencing psychotic symptoms; and not in 
previous contact with secondary mental health services for longer than 1  year.  The 
inclusion criteria for this study required patients to be in a period of clinical stability.
The exclusion criteria were a poor understanding of English or a history of head injury, 
neurological disability or leucotomy.  Demographic variables for the sample are shown 
in Table 1.
Table 1: Sample demographics
Mean age (years) 22.80







Black British Caribbean 6
Black British African 3
Asian British 10




Employment (contd.)  n
Unemployed  11
Student  8
Residential Status  n
Living with family  16
Living alone  6
Living with friends  2
Diagnosis  n
First psychotic episode  3
Schizophrenia  5
Acute Psychotic Episode  10
Paranoid Schizophrenia  4
Drug Induced Psychosis  2
Mean duration of illness (months)  19.88
Mean age of onset (years)  20.54
Mean number of relapses  0.42
Medication  n
Atypical antipsychotics  20
Typical antipsychotics  0
Depot medication  1
Mean Risperidone Equivalent Dose  2.74 
Mood stabilizers  1
Antidepressants  3
Anxiolytics  2
682.2  Design and Procedure
The study was approved by East London & the City Research Ethics Committee 
(Appendix 3).  The assessment took place in a quiet room at the EIS base.  Informed 
consent (Appendix 4) was obtained from all participants prior to their inclusion in the 
study. Participants also had the option of consenting to have a summary of their results 
included in their file at the early intervention service (see Appendix 5 for a report 
template).  Only one participant did not consent to this.  Participants completed a 60-90 
minute interview with the researcher.  Demographic information (see Appendix 6 of 
questionnaire used) was collected before the participants completed the study measures. 
In all cases the measures were completed in one session. Participants were paid £15 for 
taking part.  Within 2 weeks of each participant’s assessment the researcher met with 
their care coordinator to provide them with a report regarding the participant’s 
performance (if the participant consented to this) and to complete the measure of social 
and community functioning.
2.3  Measures
The following measures were completed in the order below.
2.3.1  Brief cognitive assessment (BCA; Velligan et al., 2004)
The BCA consists of three standard tests widely used in clinical 
neuropsychology, that tap the cognitive domains known to be impaired in schizophrenia, 
namely executive function, memory, attention and processing speed.  In Velligan et al.’s 
(2004) study, the BCA showed good inter-item consistency (Cronbach’s a = 0.77; n = 
305), and the test-retest reliability was consistent with published data.
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2.3.1.1 The Trail Making Test (TMT: Reitan & Wolfsoru 1985)
The TMT is a measure of visuomotor sequencing and comes in 2 parts.  Trails A 
measures psychomotor speed while Trails B measures psychomotor speed and the ability 
to inhibit inappropriate responses.  Trails A consists of a series of numbered circles (1- 
25), scattered at random on a worksheet.  The participant was required to draw a line 
between the circles in numerical order as quickly as possible.  Trails B has both numbers 
and letters arrayed in a random order.  The participant was required to draw lines 
between numbers and letters in an alternating sequence (i.e. 1-A-2-B-3-C etc.), again as 
quickly as possible.
In this task the score is based on time alone.  The researcher pointed out errors if 
they occurred, and the participant was required to correct the error before continuing 
with the test. A cut-off time of 300 seconds was imposed to allow comparison with 
Velligan et al.’s (2004) study.
2.3.1.2 Verbal Fluency (Benton & Hamsher. 1978)
Verbal Fluency is a test of executive function.  In the first part of the task the 
participant was asked to generate as many words as possible beginning with certain 
letters of the alphabet (F, A and S).  In the second part of the task the participant was 
asked to name as many different types of animals as possible.  The score for each part 
was the total number of words generated in one minute.
2.3.1.3 The Hopkins Verbal Learning Test (HVLT) (Brandt. 19911
70Empirical Paper
The HVLT is a list learning exercise that assesses verbal learning over 3 trials. It 
consists of a list of twelve nouns that are drawn from three different semantic categories 
with four nouns coming from each category.  The list was read aloud to the participant, 
and their free recall of the list was recorded.  The procedure was repeated twice making 
a total of three trials.  After a delay of20-25 minutes, the participant was asked if they 
could recall any words from the list.  The score was the total number of words generated 
from the 3 learning trials.
2.3.2  Theory of Mind (ToM) Tasks
There were three ToM tasks used in this study.
2.3.2.1  ToM Stories (Frith & Corcoran. 1996)
Four ToM stories were read aloud to each participant.  Two of the stories were 
‘first order’ in which a story character has a false belief about a particular situation. The 
other two stories were ‘second order’ in which a story character has a false belief about 
the belief of another character.  While the stories were read aloud, corresponding cartoon 
pictures were shown to each participant.  For each story, the participant had to answer 
two questions: The first question assessed understanding of the character’s false belief 
and required intact ToM. The second question assessed memory for the story. Scores 
were only considered if the participant correctly answered the memory question (Frith & 
Corcoran, 1996).  The ToM Stories score reflected the percentage of ToM questions that 
were answered correctly when their corresponding memory question was also answered 
correctly.
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2.3.2.2 Picture Sequencing Task (Langdon et al. 1997)
This task consists of stories depicted in black and white drawings.  Each story is 
presented on four cards.  There are two practice sequences and three experimental 
sequences: social script, mechanical and false belief.  Social script stories depict people 
acting out everyday social routines and test knowledge of logical routines using social 
script knowledge (involving no appreciation of mental states).  Mechanical stories depict 
cause and effect sequences and test ability to infer causal relations.  False belief stories 
depict the story character acting on the basis of false beliefs; these stories are the test of 
Theory of Mind. There were four stories in each experimental sequence, and the story 
presentation was randomized (Langdon et al., 1997).  The participant was presented with 
each set of story cards placed face down and was required to turn the cards over and to 
order them in a logical sequence.  The order of card placement and the time taken to 
complete each story was recorded.  The scores were the average time taken to complete 
each sequence and the average score for each sequence.
2.3.2.3 Hints Task (Corcoran. Mercer. & Frith. 1995)
This task consists of ten short vignettes presenting an interaction between two 
characters.  Each vignette was read aloud to the participant, and was repeated if the 
participant asked.  At the end of each vignette, one of the characters gave an obvious 
hint.  The participant was asked to infer what the character really meant by what he/she 
said.  A correct response was given a score of 2.  If an inference was not made or if an 
inappropriate conclusion was drawn, the participant was given additional information in 
the form of a more obvious hint.  If a correct response was given at this stage, a score of
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one was given.  If the participant failed to infer what the character meant a score of zero 
was given.  The recorded score was the total score for the ten vignettes.
2.3.3 The Wechsler Abbreviated Scale of Intelligence (WASI) (Psychological 
Corporation, 1999)
The WASI provides a reliable and brief test of IQ comparable to the WAIS-III 
(Wechsler, 1997).  The two-subtest form of the WASI was used, which can be 
administered in about 15 minutes.  This includes vocabulary and matrix reasoning and 
provides an estimate of hill scale IQ.  The two-subtest form of the WASI has shown 
good reliability (0.96) and test-retest reliability (0.88) (Psychological Corporation,
1999).
2.3.4 The Brief Psychiatric Rating Scale (BPRS; Ventura, Green, Shaner, & 
Lieberman, 1993)
The BPRS is a clinician-rated tool designed to assess the nature and extent of 
psychopathology in patients with psychotic illness over the two weeks prior to interview. 
Participants are rated on 24 different symptom constructs according to a seven-point 
scale ranging from ‘not present’ to ‘extremely severe’.  A total score is obtained from 
these ratings with lower scores indicating better functioning. In the analyses, the factor 
structure used by Velligan et al. (2005) for the negative symptom/retardation factor 
(blunted affect, emotional withdrawal, psychomotor retardation) and the psychosis factor 
(unusual thought content, hallucinations, conceptual disorganisation, bizarre behaviour) 
was used. The intraclass correlation coefficient of 0.95 for the BPRS items is excellent 
(Community Mental Health Evaluation Initiative (CMHEI) Working Paper, 2001).  AEmpirical Paper
dual-rating technique was incorporated into the research design with the aim of 
maximising the reliability of ratings.  This involved the principal researcher and a 
clinical psychologist (GP) rating a subset of the interviews independently and comparing 
ratings. However, no participants consented to being audio taped for dual rating, so it 
was not possible to dual rate the BPRS.
2.3.5 Global Assessment of Functioning Scale (GAF; American Psychiatric 
Association, 1994)
This measure is a tool for Axis V assessment in DSM-IV (APA, 1994).  It was 
completed by the researcher to assess overall functioning at the time of assessment.  The 
GAF scale is a 100-point scale that measures patients’ overall level of psychological, 
social, and occupational functioning on a hypothetical continuum. The upper end of the 
scale indicates superior functioning, while the lower end of the scale indicates severe 
impairment of functioning.  The inter-rater reliability of the GAF is good (ICC/k=0.60- 
0.75) (Fleiss, 1981).
2.3.6 Multnomah Community Ability Scale (MCAS) (Barker, Barron, 
McFarland, & Bigelow, 1994)
The MCAS was completed by the participant’s care coordinator.  It consisted of 
17 items used to assess disability associated with chronic mental illness over the 
previous month in persons living in the community.  The MCAS provided a global 
measure of functioning across four domains: interference with functioning, adjustment 
to living, social competence and behavioural problems.  Each item was rated on a five
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point scale with higher scores indicating better functioning.  The researcher was present 
during ratings to clarify what the items meant and to answer any questions posed by the 
care-coordinators.  The reliability of the MCAS is good with an intraclass correlation 
value of 0.97 (Community Mental Health Evaluation Initiative (CMHEI) Working 
Paper, 2001).
3.  Results
3.1  Scores on the measures
The mean (SD) administration time for the BCA was 14.58 (2.28) minutes.  The 
mean (SD) time taken to complete the whole experimental battery was 68.96 (10.63) 
minutes.  Following the procedure used in Velligan et al.’s (2004) study, raw scores for 
each of the subtests of the BCA were converted into z-scores by subtracting the obtained 
score on each test from the mean score for the appropriate normative sample and 
dividing this by the standard deviation for that normative sample.  The z-scores therefore 
reflect the degree of deviation of the patient group from the published normative data.  A 
global cognition function score (GCFS) was then calculated by averaging the five 
individual z-scores.  Normative data for TMT were derived from Fromm-Auch and 
Yeudall (1983) for 18-19 year olds and from Kennedy (1981) for 20-30 year olds. 
Normative data for Verbal Fluency were derived from Yeudall, Fromm, Reddon and 
Stefanyk (1986) and Seines et al. (1991) for letter and category fluency respectively, and 
HVLT norms were obtained from Brandt and Benedict (2001).  Norms were stratified by 
age for each subtest except category fluency where norms were stratified by years of 
education.  The mean z-scores and standard deviations for the individual subtests and the 
GCFS are shown in Table 2.  Before calculating the GCFS, one outlier on Trails B was
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recoded to one score higher than the next highest score following the procedure of 
Howell (1992).
Table 2. Mean z-scores and standard deviations for the BCA subtests and GFCS
Measure Mean z- Score Standard Deviation 
(SD)
Trails A -2.09* 1.78
Trails B -1.54 1.97
Verbal Fluency Letters (FAS) -1.07 1.02
Verbal Fluency Categories (Animals) -1.31 1.01
Hopkins Verbal Learning Test (HVLT) -1.71 1.31
BCA  -   Global  Cognition  Function  Score -1.52 0.85
(GCFS)
*> 1.96, p < 0.05 (Tabachnick & Fidell, 2001)
The patient group was impaired relative to norms on all of the subtests of the 
BCA.  They were most impaired on Trails A with a score of approximately 2 SDs below 
the mean of the normative sample.  Consistent with Velligan et al.’s (2004) finding the 
patients were less impaired on Trails B than A.  In addition, the patients in this sample 
showed a similar level of impairment on Trails A and B to Velligan et al.’s (2004) more 
chronic schizophrenia sample that had mean z-scores of -2.10 and -1.62 respectively.
The patients were least impaired relative to norms on Verbal Fluency Letters (FAS).
Following Velligan et al.’s (2004) study, the reliability of the BCA in the present 
sample was measured by calculating its internal consistency.  Using the z-scores
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generated from each subtest, the inter-item consistency was modest (Cronbach’s a = 
0.58; n = 24).  This compares to a = 0.77 in Velligan et al.’s (2004) study, although they 
had greater statistical power with a sample size of 305 participants.
3.2  Summary of scores on other measures
Descriptive statistics for the other measures used in the study are summarised in 
Table 3.
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Table 3:  Descriptive statistics for scores on the other measures
Measures n Range Mean Standard
Deviation
WASI FSIQ 23 56-119 89.30 16.64
ToM Hints 24 8-20 15.67 3.24
ToM Stories total % correct 24 0-100 77.08 30.02
first order % correct 24 0-100 81.25 28.79
second order % correct 24 0-100 77.08 36.05
Picture Sequencing Task - time 
false belief /secs
24 16.52 - 44.70 28.89 9.54
social script /secs 24 10.89 - 40.24 21.31 6.71
mechanical /secs 24 14.80 - 50.8 27.66 9.52
Picture Sequencing Task -  score
false belief 24 0.50 - 6 3.91 1.41
social script 24 3.25 - 6 5.09 0.93
mechanical 24 0.75 - 6 4.68 1.23
Total MCAS score 24 47-80 67.46 8.22
Total BPRS score 24 26-57 35.71 8.17
Total GAF score 24 60 - 100 86.88 11.96
One data point was missing on the WASI because one participant did not 
understand the Matrix Reasoning subtest and did not score any items correctly.  The 
patients were more impaired on the second order than the first order tasks, though this
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difference was not significant (t (23) = 0.53,/? = .60).  On the picture sequencing task, 
the patients took longest to complete and scored relatively lowest on the false belief 
subtest.  There were significant differences between the false belief score and the 
mechanical score (t (23) = -3.33, p = .003) and between the false belief score and the 
social script score (t (23) = 4.28, p = .001).  There was no difference between the social 
script score and the mechanical score (/ (23) = 1.58,/? = .13). Regarding the time taken 
to complete each sequence, there were significant differences between the social script 
and mechanical sequences (t (23) = -5.71,/? = .001) and between the social script and 
false belief sequences (t (23) = -6.99, p = .001).  There was no difference between the 
false belief and mechanical times taken to complete the sequences (/ (23) = 1.45,/? = 
0.16).  Scores on the MCAS and GAF indicated generally good social and community 
functioning.  The participants scored approximately 87 on the GAF, which is within the 
range of “good functioning in all areas”.  The maximum score on this measure is 100. 
There are no normative data on the MCAS for comparison.  However, the mean score 
for a chronic schizophrenia group of patients (n=240) on the MCAS was 55.4 (SD 9.7), 
which suggested that the first episode sample of participants was functioning at a much 
higher level with a mean score of67.46 (SD 8.22) (Barker et al., 1994), which indicated 
little psychopathology on the days of testing.  The maximum score achievable on the 
BPRS is 85.
The IQ data did not deviate significantly from normality as shown by the 
Kolmogorov-Smimov test (Z) = 0.09, p = 0.20), and the median and mode IQs were both 
92.  The mean IQ of 89.3 was lower than the average score of 95.2 (n= 92) quoted in 
Townsend et al.’s (2001) study of FEP.
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Some distributions of variables appeared slightly skewed.  However, when the 
significance test for skewness was performed (Tabachnick & Fidell, 2001) it was 
revealed that all distributions did not significantly differ from normality as summarized 
in Table 4.
Table 4:  Significance test for skewed variables
Skewed variables Skewness/ 
Standard error
z score P
WASI FSIQ -0.11 / 0.48 0.23 <1.96 n.s.
ToM Hints -0.79/0.47 1.68 <1.96 n.s
Picture Sequencing Task - time 
false belief / secs
0.28/0.47 0.6
<1.96 n.s
social script /secs 0.81 / 0.47 1.72 <1.96 n.s
mechanical /secs 0.45 / .47 0.96 <1.96 n.s




social script score -0.41 / 0.47 0.87 <1.96 n.s
mechanical score -0.39/0.47 0.83 <1.96 n.s
Total MCAS score -0.62/0.47 1.32 <1.96 n.s
Total BPRS score 0.56/0.47 1.19 <1.96 n.s
Total GAF -0.79/0.47 1.68 <1.96 n.s
GCFS -0.73/0.47 1.55 <1.96 n.s
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3.3  Relation between GCFS and community functioning
In the following analysis, multivariate statistics were not used because of the 
relatively low sample size in the study.  A Pearson’s product-moment correlation 
between global cognition score on the BCA (GCFS) and community function (MCAS 
total score) revealed r (24) = 0.36; p = 0.04, 1-tailed, indicating a moderate statistically 
significant positive relationship between patients’ GCFS and their community function. 
This is similar to Velligan et al.’s (2004) finding of a positive relationship between 
GCFS and MCAS (total score) (r (24) = 0.42; p <  0.02, 1-tailed).
3.4  Other correlates of GCFS
A Bonferroni correction was performed to reduce Type I error in these analyses; 
as 6 statistical tests were used, ap value of .008 (.05/6) was used to indicate statistical 
significance.  To investigate the association between GCFS and IQ, a Pearson’s product- 
moment correlation was calculated.  This was highly statistically significant (r (24) =
0.59; p =  .002, 1-tailed), showing as would be expected that these measures were 
strongly and positively correlated.  GCFS was positively and significantly correlated 
with GAF score (r (24) = 0.62; p = .001, 1-tailed).  The association between GCFS and 
the psychosis factor of the BPRS was not statistically significant (r (24) = -0.18;/? = .20, 
1-tailed), which is consistent with other studies that show little relation between the 
positive symptoms of psychosis and cognitive function (e.g. Gold & Harvey, 1993).  The 
association between GCFS and the retardation factor of the BPRS was not significant (r 
(24) = -0.34,/? = .054, 1-tailed), and neither was the association between GCFS and 
medication (in Risperidone equivalent dosage) (r (23) = -0.36; p =  .04,1-tailed).
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Finally, the association between GCFS and duration of illness was not significant (r (24) 
= 0.10;/? = .32,1-tailed).
3.5  Relation between ToM scores and MCAS
A Bonferroni correction was performed to reduce Type I error; as 7 statistical 
tests were used in the analyses of ToM, a p value of 0.007 (0.05/7) was used to indicate 
statistical significance.  Only Hints total was positively and significantly associated with 
MCAS total (r (24) = 0.493; p —  0.007,1-tailed).  The relationship between ToM 
Stories total % correct and MCAS total score was not significant (r (24) = 0.37; p = .04,
1-tailed), and neither was the relation between MCAS total score and first order % 
correct (r (24) = 0.42, p =  .02,1-tailed).  Second order % correct was not significantly 
associated with MCAS total (r (24) = 0.26, p = .11).  None of the Picture Sequencing 
Task average scores were related to MCAS total score: false belief sequence and MCAS 
(r (24) = 0.38; p = .03, 1-tailed); mechanical sequence and MCAS (r (24) = 0.39; p =
.03, 1-tailed); social script sequence and MCAS (r (24) = 0.20;p =  .17, 1-tailed).
3.6 Other correlates of community functioning
Pearson’s product-moment correlations were calculated to investigate the 
relations between community functioning (MCAS total score) and other variables. A 
Bonferroni correction was performed to reduce Type I error; as 5 statistical tests were 
used, a p value of 0.01 (0.05/5) was used to indicate statistical significance.  There were 
significant associations between IQ and MCAS (r (24) = 0.50; p = .007,1-tailed), and 
between the retardation factor of the BPRS and MCAS (r (24) = -0.51;/? = .005, 1- 
tailed).  There were no associations between MCAS total score and the psychosis factor
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of the BPRS (r (24) = -0.22; p = .16, 1-tailed) or duration of illness (r (24) = 0.12; p =  
.30, 1-tailed) or medication dosage (in Risperidone equivalents) {r (24) = -0.27, p =  .11,
1-tailed).
3.7  Regression analysis
Analysis of the distribution of residuals revealed they were normal (D =  0.146, p 
= .20).  A multiple regression was performed in order to explore the varying 
contributions of IQ, GCFS, retardation factor of BPRS and Hints score (ToM) in 
predicting community function (MCAS total score).  The dependent variable in this 
regression was MCAS total score, and the independent variables were GCFS, IQ, 
retardation factor of BPRS and Hints.  Overall, this model was significant (F (4,18) = 
3.23,p =  0.036), with adjusted R-square calculated to be 0.289, meaning that 28.9% of 
the variance in community function was explained by the independent variables GCFS, 
IQ, retardation factor of BPRS and Hints scores.  In terms of independent effects, neither 
IQ (Beta = 0.101,/? = .76) nor GCFS {Beta = 0.1 \,p = .67) nor retardation factor of 
BPRS {Beta = -.304, p = .153) nor Hints {Beta = 0.30, p = .33) were significant 
predictors of MCAS total score.
4.  Discussion
This study examined the use of a new measure for brief cognitive assessment, the 
BCA, in a FEP population.  As only one published study to date (Velligan et al., 2004) 
has used this measure in a chronic schizophrenia population, the present study was the 
first to assess its use in an FEP population. In contrast to Velligan et al.’s (2004) study, 
this study incorporated a number of additional measures, which examined Theory of
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Mind, current IQ and symptomatology.  The relationship of these variables to BCA 
score and community functioning (MCAS) was explored.  Theory of mind has received 
very little attention in the FEP literature, and this study is among the first to explore this 
construct using a variety of ToM measures.
4.1  Discussion of the results in relation to the hypotheses
The first hypothesis that the FEP participants would be significantly impaired 
relative to normative data was only partially supported by the findings.  Although the 
FEP patients were impaired relative to normative data on all subtests of the BCA, the 
only statistically significant difference was on Trails A.  In Velligan et al’s (2004) study 
their participants were significantly impaired on all subtests of the BCA except Trails B 
(z = 1.62, SD = 1.13).  The difference between our findings may be explained by the 
more chronic presentation of Velligan et al.’s (2004) participants whose cognitive 
functioning appeared to be more compromised than that of the participants in the present 
study.  However, there are also similarities between ours and Velligan et al.’s (2004) 
findings that are note worthy. Firstly, in both studies the participants were less impaired 
on Trails B than A and showed a similar level of impairment on each of these tasks 
despite the larger sample size used in Velligan et al.’s (2004) study (n=340) and their 
more chronic presentation.  This finding was counterintuitive as Trails B appears to be a 
more demanding task measuring psychomotor speed and the ability to inhibit 
inappropriate responses, while Trails A only assesses psychomotor speed.  This result 
may reflect a practice effect, as Trails A was administered before Trails B, which may 
have given the participants an advantage on the psychomotor aspect of Trails B thus 
allowing them to concentrate better on the response inhibition part of the task.  A second
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similarity between our findings relates to Verbal Fluency tasks where both groups of 
participants were more impaired on the Categories than the Letters subtests.  A 
differential impairment on Verbal Fluency Categories has been reported in other studies 
of schizophrenia and may reflect a compromised semantic system in those with 
schizophrenia (Bokat & Goldberg, 2002; Elvevag, Weinstock, Akil, Kleinman, & 
Goldberg, 2001).
Consistent with the second hypothesis, the Global Cognition Function Score 
(GCFS) on the BCA correlated positively with community functioning as measured by 
the MCAS.  This is supported by Velligan et al.’s (2004) finding of an association 
between the BCA and the MCAS.  These results suggest that the BCA may be a useful 
predictive measure of community functioning.
The third hypothesis was only partially supported by the findings.  Our results 
showed a lack of association between the positive symptoms (as measured by the BPRS) 
of psychosis and community functioning (as measured by MCAS).  This is consistent 
with other studies, which showed weak evidence for an association between positive 
symptoms and community function (Green 1996; 2000).  This suggested that in the 
present sample, GCFS was a better predictor of community functioning than the positive 
symptoms of psychosis, which again is consistent with other studies (e.g. Green, 1996; 
Green et al., 2000; Velligan, Bow-Thomas, Mahurin, Miller, Halgunseth, 2000).  There 
was a significant association between the negative symptoms of psychosis (as measured 
by the BPRS) and MCAS total.  There are mixed findings in the literature regarding an 
association between negative symptoms and community functioning, and in Green’s 
review (1996) negative symptoms were found to be inconsistently related to community 
outcome.  In the regression analysis, neither the negative symptoms of psychosis norEmpirical Paper
GCFS were independent predictors of community function.  The sample size used in the 
present study may not have been large enough to detect a significant effect where there 
was one (Type II error).  Future studies would benefit from exploring this link further 
using larger sample sizes than the one used in the current study.
The fourth hypothesis that BCA would be more closely related to level of 
community functioning than IQ was not supported, as the correlation between IQ and 
MCAS was greater than between BCA (GCFS) and MCAS.  This suggested that IQ in 
addition to the BCA (GCFS) may be a useful predicator of social and community 
functioning.  Neither IQ nor GCFS were significant independent predictors of 
community functioning in the regression analysis.  Again, the small sample size used 
may not have generated enough statistical power to detect a difference where there was 
one.
The fifth hypothesis was not supported by the findings.  Although the Hints Task 
was positively and significantly related to MCAS total score, it was not a significant 
independent predictor of community function in the regression analysis.  This result may 
have been due to the small sample size used.  The relationship between ToM and 
community functioning has been confirmed in other studies, and ToM has been shown 
to be more related to community function than neurocognition (Briine, 2005; Pinkham & 
Penn, 2006; Pollice et al., 2002).  In the present study, IQ was more correlated with 
community function than the BCA (GCFS).  Future studies would benefit from 
exploring the predictive power of ToM and community functioning using a larger 
sample size.
In addition to the above findings, GCFS was not associated with medication or 
duration of illness.  These were important findings because they suggested that
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medication and duration of illness were not acting as confounding factors in the present 
study, as they were not significantly associated with cognitive impairment.  This finding 
should be interpreted with caution due to the small sample size (u=21), which may have 
resulted in insufficient statistical power to detect a relationship between medication and 
cognitive impairment when in fact there was one (Type II error).  Nevertheless, these 
results reflect other findings in the literature regarding a lack of association between 
cognitive function and duration of illness (Prikryl et al., 2003).
4.2  Strengths and limitations of the study
The strengths and limitations of this study must be considered when interpreting 
the results.  In terms of strengths, this study was the first to administer the BCA in an 
FEP population. Despite the small sample size, the BCA showed modest internal 
consistency, further supporting its validity and use as a brief assessment of cognition in 
schizophrenia.  Consistent with Velligan et al.’s (2004) study, the measures that 
comprise the BCA took approximately 15 minutes to administer, which adds further 
weight to its usefulness in a clinical setting as it gives an overview of the main cognitive 
domains known to be impaired in psychosis, in a brief space of time.
In contrast to Velligan et al’s (2004) study, the current study 
incorporated a number of additional measures into its design including the WASI, ToM 
measures and the BPRS.  These additional measures were used to explore the 
independent contributions of IQ, ToM and symptoms to participants’ levels of 
community and cognitive function.  Psychosis is a complex area, which was reflected in 
the design and analysis of this study.  Although this study reflected these complexities, it 
remained hypothesis driven so as not to become overwhelmed by them.
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There are also some limitations to this study that are worth noting.  Firstly, the 
sample size was small and had fewer participants than the power calculation 
recommended.  The difficulty recruiting participants was due to factors related to FEP 
generally (e.g. poor engagement, relapse and hospitalization) and issues within the 
services I recruited from (high turnover of staff, little time for staff to help with 
recruitment).  The small sample size increased the risk of Type II error, that is, lack of 
power to detect an effect when in reality one exists.  Unfortunately, difficulty recruiting 
participants reflects the inherent obstacles to research in this area that future researchers 
could try to address by approaching more services thus gaining a larger pool of potential 
participants to draw from.
Secondly, although all of the participants were fluent in English, half of the 
sample did not speak English as a first language, which may have impacted on their 
understanding of and scores on the tests.  This corresponds to the cultural diversity of 
the participants, who were recruited from an area of London that has a high 
concentration of minority ethnic groups.  The high number of participants from minority 
ethnic groups may also reflect the reported increased incidence of psychotic illness 
among these groups (Fearon et al., 2006).  As is often the case in neuropsychological 
testing, the norms used for comparison with the BCA measures were based on English 
speaking populations who were predominantly Caucasian.  These cultural and linguistic 
differences between the participants and norms may have led to inaccurate comparisons 
between the two groups, which may have confounded the results.  There is an urgent 
need for norms that reflect cultural diversity from which to make comparisons with 
those with psychotic illness.
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The MCAS was completed by the participants’ care-coordinator.  While the care- 
coordinators generally provided an objective and well informed perspective on the 
participants’ abilities, it may have been beneficial to incorporate information from other 
sources.  Briine (2005) noted that nursing staff generally underrated patients when they 
completed a measure of social functioning (Social Behaviour Scale; Wykes & Sturt,
1986) perhaps because they were used to ‘oddities’ or ‘habits’ of the patients they were 
rating.  In consideration of this, future studies might benefit from incorporating 
information from the clients themselves, clinical reports and the Responsible Medical 
Officer when rating the MCAS.  Also, because many different care-coordinators 
completed the measure across two different services, inter-rater reliability was an 
important issue to ensure that the different care coordinators were completing the MCAS 
based on the same criteria.  In consideration of this issue the researcher was present each 
time the questionnaire was completed to answer any questions about the MCAS items. 
Briine (2005) recommended that staff should be trained in the use of measures such as 
the MCAS, which future studies might consider.
Unfortunately, none of the participants consented to being audio taped for dual 
rating  on  the  BPRS.  This  may  have  been  due  to  symptoms  of psychosis  such  as 
paranoia or a lack of motivation to be taped, as it did not affect their participation in the 
study or the financial incentive they received.  Due to time constraints, my supervisor 
was unable to attend the assessments to observe and rate the BPRS.  Perhaps if a larger 
number of participants had been recruited there would have been a greater chance of 
some of them consenting to be audio taped.
4.3  Recommendations for future studies
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In addition to the recommendations outlined above, future studies might consider 
which aspects of ToM relate to community functioning, thus moving from exploratory 
studies to hypothesis driven ones.  Pinkham and Penn (2006) looked at social cognition 
by breaking this construct down into three domains: emotion perception, social 
knowledge and ToM.  They found that social cognition contributed significantly more 
variance to interpersonal skill than neurocognition and concluded that social cognition 
may not be best characterised by one specific deficit but by the impairments that span 
the range of social cognitive skills.  Community functioning might also be broken down 
into its constituent parts.  This might be achieved through incorporating functional 
assessments of living skills (e.g. Functional Needs Assessment; Domborwski, Kane, 
Tuttle, & Kinceid, 1990) into assessment batteries so that direct assessment of these 
skills could be observed in addition to collecting information via questionnaires.
Velligan et al. (2004) used the Functional Needs Assessment as well as the MCAS to 
assess community functioning, and both measures were correlated with the BCA.
It would also be interesting for future studies to gather information from the 
participant regarding their self perception of cognitive deficits to see if this bears any 
relationship to the measures used to assess these domains.  As part of the study, I fed 
back individual participants’ results upon their request, and several participants offered 
further information about these deficits shedding light on how they manifested in day to 
day function and were experienced by the participant.  This information was then used in 
targeted interventions.  Stip, Caron, Renaud, Pampoulova and Lecomte (2003) used the 
Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS) to assess memory 
(working, explicit long-term memory), attention (divided, distractibility, alertness, 
sustained), language, and praxia in those with schizophrenia.  The SSTICS was shown to
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have good internal consistency and stability over time and was correlated with objective 
cognitive assessments.  Future studies might benefit from incorporating this measure in 
addition to objective neuropsychological tests.
4.4  Implications of the findings
Our results showed that patients with FEP are impaired relative to normative data 
on the cognitive domains of memory, attention and executive function, though only 
performance on Trails A was significantly different from norms.  The larger sample size 
and more chronic population examined in Velligan et al.’s (2004) study make direct 
comparisons with this study difficult.  However, the participants in Velligan et al.’s 
(2004) study were significantly more impaired on the BCA, which suggests that 
cognition may become more impaired as psychotic illness progresses.  This impairment 
is something that needs to be addressed, and its implications can no longer be 
overlooked.  Interventions aimed at reducing the impact of the cognitive deficits may 
reduce the long term social consequences of psychosis for individuals.
Cognitive rehabilitation has been increasingly cited as an essential component of 
comprehensive treatment (Kern & Green, 1998; Storzbach & Corrigan, 1996).
Cognitive rehabilitation approaches seek to enhance cognitive processes or to 
circumvent cognitive impairments in schizophrenia in an effort to improve functional 
outcome (Velligan, Kern, & Gold, 2006).  This is potentially very important with first 
episode populations where cognitive rehabilitation could have a significant impact on 
the person’s quality of life and community functioning.  The BCA may be used to assess 
neurocognitive abilities and to place patients on different rehabilitation tracks based on 
the results of their assessment.  For example, if a patient has deficits in verbal memory,Empirical Paper
more repetition of verbal instructions may be needed, which could be incorporated into 
their rehabilitation program (Velligan et al., 2006).
The BCA may also be used by mental health professionals to assess changes in 
cognitive function over the course of treatment.  The BCA was straightforward to 
administer and score and would be relatively simple to train a wide range of mental 
health professionals to use. It was also brief, which prevented fatigue among the 
participants, and they appeared to enjoy the tasks and seemed motivated to perform their 
best. These are important aspects of any cognitive assessment that is to be widely and 
routinely used in this population, both in terms of persuading staff to administer it and 
encouraging patients to complete it.
4.5  Conclusion
In summary, the purpose of this study was to examine the relationship between 
cognitive and community functioning in FEP.  The BCA (GCFS) score and ToM Hints 
task were related to community functioning.  Although neither BCA nor ToM were 
significant independent predictors of community function in a regression analysis, future 
studies should explore this relationship further using larger sample sizes.  This study has 
provided additional evidence of subtle cognitive deficits in FEP (Sweeney, Haas, Kelip, 
& Long, 1991; Hutton et aL, 1998; Riley, et aL, 2000) and highlights the need for a 
standardised way of assessing these.  The BCA is a simple, brief and reliable assessment 
of the domains consistently reported to be impaired in psychosis and may have a future 
role in psychosis services to provide a baseline measure of cognitive function and to 
monitor change over time.  This is particularly pertinent in FEP where quick assessment 
and intervention may have a significant impact on future course of illness.Empirical Paper
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100Part 3:  Critical AppraisalCritical Appraisal
The following part of my thesis will reflect on the process of conducting this 
research. I will focus in particular on the experience of working in the early intervention 
service (EIS), recruitment, the writing of reports regarding the participants’ results, and 
the selection of assessment measures.
1.  Experience of working with the EIS teams
Participants were recruited from two EISs in the hope that enough would be 
recruited.  One other EIS was approached but declined to take part in the research 
project.  Although both teams were early intervention in psychosis teams, they were very 
different in terms of their ethos.  One team was led by a clinical psychologist and had 
more psychologists working in it than the other team, which was led by a psychiatrist 
and mainly composed of nurses and social workers.  Because of their training and 
experience, the team with greater psychology input was more familiar with the process 
of research and had a greater understanding of the project.  The other team seemed a 
little suspicious of the project initially, and they needed reassurance that the research 
would not harm their clients and was not an evaluation of their work or the service.
Both services were very busy, and at times I felt as though my research was at the 
bottom of their agenda.  Although this was disappointing, it was inevitable given the 
work pressures on the staff in the EISs.
2.  Recruitment
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One weakness of this study was the numbers of participants recruited, which 
were 16 less than the power calculation recommended.  There were a number of factors 
that impinged on recruitment, which were as follows:
I collected data from two EISs in order to maximise recruitment.  There were 
three other research projects taking place between the two teams who consented to take 
part, which impacted on my ability to recruit participants.  Although these projects 
focused on different topics, the care coordinators (CCs) were reluctant to approach 
clients who had already taken part in another study, fearing it might hamper engagement 
with the EIS.  Also, despite the financial incentives offered, many of the clients were 
reluctant to take part in multiple research projects over a short period of time.  The 
number of concurrent research projects also led to confusion from the CCs about the 
focus of different projects, and anxiety about the increased demands on their time in 
terms of recruitment.  The difficulties with recruitment and the high number of 
concurrent research projects taking place in the EISs may reflect the increasing research 
interest in EISs and first episode psychosis (FEP).  It may also reflect the increasing 
numbers of trainee clinical psychologists working in the National Health Service (NHS) 
who are required to conduct research as part of their training.
The recruitment protocol was decided upon after meetings with the service 
managers and Responsible Medical Officers (RMO) from the two services who took 
part.  Initially the recruitment protocol was; 1) the researcher (AW) met with each CC to 
identify suitable participants from their caseload; 2) the RMO approved/disapproved that 
the client(s) identified from the CCs’ caseloads were suitable to take part; 3) the CC 
gave an approved client an information leaflet about the study, and asked their consent 
for the researcher to contact them; 4) if the client gave consent, the researcher contacted
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them to answer any questions they had about the study and arranged a time to meet if 
they were interested in taking part.
There were a number of problems with stage one of this protocol that impacted 
on recruitment.  When the CCs were emailed or asked in person to arrange a time to 
meet about the research, some CCs did not reply to the emails or said they were too busy 
to meet at that time.  This often delayed recruitment and was perhaps indicative of the 
priority of the research project in their busy schedules.
Of the CCs who agreed to meet, many of them deemed lots of the clients on their 
caseload unsuitable to take part despite the inclusion criteria being quite broad 
(Appendix 1).  Each CC had a caseload of approximately 15 clients, and the highest 
number of clients identified from the CCs’ caseloads was approximately 1-3.  It was 
difficult to identify why so many participants were thought unsuitable.  Often the CCs 
gave reasons such as “they won’t engage with me so they probably won’t engage in the 
study”, even though I was offering a financial incentive to take part.  This presented a 
dilemma for me between challenging the reasons why most clients were deemed 
unsuitable to take part or remaining quiet in an effort to keep the CCs on board with the 
study.  After discussion with my supervisor, I chose not to challenge the CCs about why 
so many of their clients were unsuitable to take part, as I was new to the team and did 
not want to antagonise its members.  In hindsight, perhaps it would have benefited 
recruitment to be more challenging.
In stage two of the recruitment protocol the RMO generally approved most 
clients identified as suitable to take part.  However, this often delayed stage three of the 
protocol, as it often took the RMO a long time to sanction whether or not the clients 
were suitable.  The RMO’s involvement at this stage in the protocol also perhaps
104Critical Appraisal
undermined the CCs’ decisions about who was suitable to take part.  However, this was 
an unavoidable dynamic in the service, which was quite hierarchical.
Regarding stage three of the recruitment protocol, it took varying lengths of time 
for the CCs to approach the clients identified about the study.  This was often due to 
forgetting to give an information leaflet to the participant when they met, engagement 
problems on the clients’ part and concerns from the team about the clients’ mental state. 
The CCs were very busy, and it often seemed as though giving information leaflets to 
the clients they identified placed an extra burden on them.  Some CCs expressed anxiety 
about the level of knowledge they were expected to have about the study.  To minimise 
their anxiety and to limit the information given by CCs to clients, the CCs were 
instructed to say, “There’s a research project running in the service and we thought you 
might be interested in taking part”.  The CCs were then asked to give the client the 
information leaflet and not to answer any questions about the study.  If the client had 
some queries, they were instructed to direct the client to the information leaflet or offer 
that the researcher would contact them to answer their questions.  Despite these 
instructions, some CCs relayed misinformation about the study to the clients.  For 
example, when I contacted one client she reported that she did not want to take part 
because she did not want to talk about the events that precipitated her onset of psychosis. 
When I informed her that no part of the study required that information she seemed 
surprised and said that her CC had told her she would probably have to talk about these 
experiences.  Also, as there were three other research projects being conducted between 
the two EISs, the CCs sometimes understandably confused the various projects.
In the final stage of the recruitment protocol, few clients declined to take part 
when I contacted them to arrange a time to meet.  However, some frequently cancelled
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their appointments or did not attend.  Those who did not want to be contacted about the 
study often did not give reasons for this.
In the first few months of the project, there was a very low referral rate to the 
study.  As a consequence, I met with the RMO to discuss ways to increase recruitment, 
while reducing dependence on the CCs.  The RMO suggested that he would identify 
suitable clients to take part and that I should then ask the CCs if it would be alright to 
send the clients identified from their caseload an information leaflet about the study. 
Although the RMO identified a high number of clients to approach, gaining the CCs 
consent to contact their clients was still a barrier.  Often their reasons were unclear, but 
many were concerned that the client was not properly engaged in the service and that 
asking them to take part in the study might further hamper their engagement. 
Nevertheless, this new protocol increased the numbers recruited and reduced the onus on 
the CCs to identify suitable clients and give them information leaflets.  After sending 
information leaflets about the study, some clients were difficult to contact due to lack of 
a telephone service, and some involvement from the CCs was needed to ask if they were 
interested in taking part.
Several extraneous factors within the teams also impinged on recruitment. In one 
team, four CCs resigned during the recruitment stage.  This meant many clients had to 
be followed up by new staff, which resulted in delays and often subsequent difficulties 
with engagement.  Also, since the new staff knew little about their clients it was difficult 
for them to identify suitable candidates for the research.  Two CCs had significant life 
events that resulted in extended absences, which also delayed recruitment and impacted 
on client engagement. Both EISs moved location whilst I was recruiting, which also
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impacted on client engagement, room bookings and the priority of my research in staff 
members’ minds.
In addition, one of my field project supervisors left the EIS before I began 
recruitment, forcing me to seek consent from the new team leader before I could begin. 
Although the team leader was open to the idea of my research, he suggested many new 
ideas, which would have changed the nature and design of the research.  Because the 
project had already received ethical approval, I was limited in the changes I could make 
and was only able to incorporate a few of his ideas.  However, this helped to get him on 
board with the project.
If I were to do a similar study again, I would initially ask the RMO for list of 
potentially suitable clients from the services’ overall caseload rather than asking the CCs 
to identify clients from their individual caseloads.  In the present study, the latter model 
of recruitment was decided upon by the RMOs and service managers at the beginning of 
the study, but was revised when it did not yield high numbers of clients to approach.
This method of negotiation and revision was a strength of the way I approached and 
conducted the study (i.e. not acting as an ‘expert’ and commanding what to do), which 
may have helped recruitment as it promoted good relationships between myself and the 
staff.
3.  Reports
Once clients took part in the study, I fed back to their CC about whether they had 
attended our meeting and whether they had given consent for a report to be provided to 
the team regarding their results (see Appendix 3 for a report template).  If the client 
consented to a report, I completed this and met with the CC within two weeks of the
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client’s participation in the study to deliver it.  I also used this opportunity to ask the CC 
to complete the Multnomah Community ability Scale (MCAS; Barker, Barron, 
McFarland, & Bigelow, 1994).  It was important to meet with the CC within this one 
month period because the MCAS ratings are based on the client’s presentation over the 
previous month.  All of the CCs agreed to complete this questionnaire, perhaps because 
they were getting something back from the study in the form of a report.
Only one client did not consent to having a report of his results included in his 
file.  Of the remaining 23 participants who consented, eight participants requested 
feedback regarding their results.  This feedback was given in person or over the phone if 
the participant did not want to arrange a meeting.  This was a difficult part of the 
research process for me as it often involved communicating sometimes poor results to 
the clients, many of whom had little insight regarding their difficulties.  However, some 
clients reported that the results fitted with their experience, for example, of having 
memory problems or difficulty placing themselves in another person’s shoes (Theory of 
Mind).  In some cases, the results provided an objective measure of what the client 
already knew but had not articulated.
Although time-consuming to write, the reports proved to be an important 
component of the clients’ care and were valued by the EIS staff.  Some staff felt 
overwhelmed by the clients on their caseloads, and the reports often provided some key 
information that changed the way the staff related to the clients and their understanding 
of clients’ difficulties.  For example, one client was very socially adept but displayed 
immature behaviour, which frustrated the staff especially when on group outings.  Based 
on his results from the assessment, his score on the Wechsler Abbreviated Scale of 
Intelligence (WASI) (Psychological Corporation, 1999) was within the learning
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disability range.  The client’s CC was initially shocked by this, perhaps because his 
social skills may have masked this deficit in IQ.  This finding led to greater 
understanding about why he acted immaturely and did not obey staff directions when out 
in the community. This particular client asked for feedback regarding his results.  I was 
initially concerned about giving him feedback because he appeared to have high self­
esteem and he was regarded by his family as “the clever one”.  However, he 
acknowledged that he often had difficulty understanding things that others appeared to 
have no difficulty understanding, but was afraid to say so.  He appeared somewhat 
relieved that there was an explanation for this.  His CC discussed this further in meetings 
with him and thought of ways he could ask for extra support when he did not understand 
things.
4.  Reflection on the choice of assessment measures used
We chose the assessment measures to reflect the domains thought to be impaired 
in FEP, namely executive function, verbal memory, attention and psychomotor speed. 
Theory of mind and IQ measures were also incorporated into the research design, as 
these areas have not received much attention in the FEP literature.  In the next section, 
the process of using each of the measures is discussed.
4.1  Brief Cognitive Assessment (BCA) (Velligan et al., 2004)
The Trail Making Test (TMT) (Reitan & Wolfson, 1985) was the first test 
administered, and many participants took longer than expected to complete the Trails A 
subtest perhaps because they were nervous or settling in to the assessment.  In general, it 
seemed as though participants found the TMT easy, which may have reduced their
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anxiety about the rest of the assessment.  Two participants reported that seeing the 
numbers printed on the page reminded them of school and studying mathematics, which 
they believed they were not good at.  This suggested that the participants’ experiences at 
school may have influenced their performance during the assessment and may have 
deterred some clients from taking part.  The potential influence of prior academic 
experiences on participants’ willingness and performance during neuropsychological 
assessment should be explored in future research.
Although all participants were fluent in English, 50% of the sample of 
participants did not speak English as a first language.  This may have influenced their 
performance on the Verbal Fluency task (Benton & Hamsher, 1978).  After completing 
this task several participants reported that they found it difficult to think of the words 
they were trying to say in English.
Some participants who had active symptoms of psychosis recalled words from 
the Hopkins Verbal Learning Test (HVLT) (Brandt, 1991) that were not in the trials or 
related to any of the words semantically or phonetically. One participant recalled the 
same set of words across the trials even though the words he was recalling were not in 
the trials.  These intrusions may have reflected thought disorder.  Information on 
intrusions is not usually recorded during administration of the HVLT or reported in 
published studies.  This information may provide a useful indicator of thought disorder 
in clients with psychosis.
4.2  Theory of  Mind tasks
The Hints task (Corcoran, Mercer, & Frith, 1995) was quite Westernised in its 
phraseology, and several participants asked me to translate some words and phrases such
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as “Ajax”, “flat broke” and “right up my street”.  The names of the characters in the 
Hints Task and Theory of Mind Stories (Frith & Corcoran, 1996) were also quite 
westernised, and many of the participants who were not from the UK may not have 
related to the stories as well as those who were from the UK.  Future researchers 
planning on using these tasks should consider these issues.  Most participants seemed to 
enjoy the Picture Sequencing Task (Langdon et al, 1997).  The non-verbal aspect of the 
task provided a good measure of theory of mind for those participants who did not speak 
English as a first language.
4.3  Other tasks
The shorter version of the WASI was used to give an estimate of full scale IQ 
only.  This incorporated a performance task (Matrix Reasoning) and a verbal task 
(Vocabulary).  As with the other verbal tasks, the Vocabulary subtest appeared more 
difficult for those who did not have English as a first language.  In neuropsychological 
assessment, there is a lack of norms for ethnic minorities and those who do not speak 
English as a first language.  This area requires further research in the future so that these 
participants are compared to culturally appropriate norms.
Cultural factors also played a role in rating the Brief Psychiatric Rating Scale 
(BPRS) (Ventura, Green, Shaner, & Lieberman, 1993), particularly the ‘grandiosity’ 
item.  When interviewed regarding this item, many participants reported that they 
believed they had special powers and abilities and a special purpose in life. A high 
proportion of the sample was Muslim, and some reported that these beliefs were related 
to their religion.  It was often difficult to explore this further with those participants,
111Critical Appraisal
perhaps due to the private nature of those beliefs and because they had reservations 
addressing these matters with a Western Caucasian female.
The General Assessment of Functioning scale (GAF) (American Psychiatric 
Association, 1994) provided a very brief and easy measure of functioning based on the 
participants’ presentation during the assessment.  This measure was correlated with the 
global cognitive function score (GCFS) from the BCA.  On reflection, it would have 
been beneficial to obtain a GAF rating from the CCs and compare it to the score taken 
on the day of the assessment.
The Multnomah Community Ability Scale (MCAS) (Barker, Barron, McFarland, 
& Bigelow, 1994) provided a good estimate of community function, which was 
correlated with GCFS and the Hints task.  The high turnover of staff in the EIS meant 
that some CCs who were new to the services were less familiar with their clients than 
other CCs.  This may have meant that some staff were not in a position to give as full a 
picture of their clients as other staff.  Unfortunately, this limitation was unavoidable but 
may have been compensated for if collateral information regarding the MCAS items had 
been obtained from other sources of information (e.g. recent reports, RMO).
Conclusion
In summary, there were a number of factors that impacted on my ability to 
recruit enough participants for this research study.  The CCs were crucial in facilitating 
the recruitment of participants.  Unfortunately, research in the NHS often seems to be a 
low priority in comparison with seeing clients and dealing with day to day 
administrative tasks.  The pressures that staff are under to meet NHS targets often mean 
that there is little time or energy to engage in research related activities.  These factors
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impacted on this research project in terms of the numbers recruited.  Several extraneous 
factors including staff turnover and CCs’ life events also impacted on recruitment.
These factors were unpredictable but reflect the reality of conducting research in the 
NHS.
Writing the reports consumed a great deal of my time and often detracted from 
recruitment.  However, they also bolstered recruitment by giving something meaningful 
back to the service thus engaging the CCs in the research project.  Providing reports on 
the clients’ results enabled me to return something of value from my research to the 
services and their clients, which improved my relations with them and therefore eased 
the process of recruitment somewhat.  The reports often played an important role in the 
clients’ care plans and the CCs’ view of their difficulties.  This illustrates how, if the 
BCA were to be used routinely by psychologists in teams, it might be a relatively 
straightforward and acceptable way of psychologists impacting on care plans for many 
clients.
Lastly, one of the key issues that arose from reflecting on the assessment 
measures used was the need for culturally appropriate norms.  The participants’ 
experience of the research process and responses to the measures may have been 
influenced somewhat by cultural differences between the researcher and participant. 
These issues are commonly reflected on in qualitative research, but less so in 
quantitative research where they are equally relevant.
113Critical Appraisal
References
American Psychiatric Association (1994).  Diagnostic and Statistical Manual of  Mental 
Disorder (4th ed.).  American Psychiatric Press.  Washington, DC.
Barker, S., Barron, N., McFarland, B. H. & Bigelow, D. A. (1994).  A community 
ability  scale for chronically mentally ill consumers: Part I. Reliability and 
validity. Community Mental Health Journal, SO, 363-383.
Benton,  A.  L.,  &  Hamsher,  K.  (1978).  Multilingual Aphasia  Examination  (manual, 
revised). Iowa City, I  A:  University of Iowa.
Brandt, J., (1991).  The Hopkins Verbal Learning Test: development of a new verbal 
memory test with six equivalent forms.  Clinical Laboratory Neuropsychology,
5, 125-142.
Corcoran, R., Mercer, G., & Frith, C. D. (1995).  Schizophrenia, symptomatology and 
social  inference:  investigating  theory  of mind  in  people  with  schizophrenia. 
Schizophrenia Research, 17, 5-13.
Frith, C. D., & Corcoran, R.  (1996). Exploring ‘theory of mind’ in people with 
schizophrenia.  Psychological Medicine, 26, 521-530.
Langdon, R., Michie, P., Ward, P., McConaghy, N., Catts, S., & Coltheart, M. (1997). 
Defective self and/or other mentalising in schizophrenia: a cognitive 
neuropsychological approach. Cognitive Neuropsychiatry, 2,  167-193.
Psychological Corporation. (1999). Wechsler Abbreviated Scale of  Intelligence (WASI) 
manual.  San Antonia, TX: Author.
Reitan,  R.  M.,  &  Wolfson,  D.  (1985).  The Halstead-Reitan Neuropsychological  Test 
Battery.  Neuropsychology Press, Tucson, AZ.
114Critical Appraisal
Velligan, D. I., DiCocco, M., Bow-Thomas, C. C., Cadle, C., Glahn, D. C., Miller, A. L., 
Biggs, M. M., Shores-Wilson, K., McKenzie, C. A., Crismon, M. L. (2004).  A 
brief cognitive assessment for use with schizophrenia patients in community 
clinics.  Schizophrenia Research, 77, 273-283.
Ventura,  M.  A.,  Green,  M.  F.,  Shaner,  A.,  &  Liberman,  R.  P.  (1993).  Training  and 
quality  assurance  with  the  brief psychiatric  rating  scale:  "The  drift  buster". 
International Journal of  Methods in Psychiatric Research, 3, 221-244.
115Appendix 1:  Inclusion Criteria and Instructions for Referring
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116Brief Cognitive Assessment in First Episode Psychosis
Allison Whitty 
Study Inclusion Criteria
1.  Client in either Tower Hamlets or Hackney early intervention services.
2. Able to sit with an interviewer for a period of time and answer questions.
3.  Aged 16-35.
4.  Fluent English speakers.
5.  Either gender.
6.  No history of head injury or neurological disability.
If you have any queries about the suitability of a patient please contact me on the 
above number.
If you have a client on your caseload who fits the above criteria:
1.  Please give them the accompanying patient information sheet about the study, and 
ask them if it would be OK for me to contact them.  (Passing on their contact details 
to me does not mean they are committing themselves to take part in the study.  I will 
contact them to answer any questions they may have.  If they would like to take part 
I will arrange a time to meet with them.  If they do not wish to take part I will not 
question why).
2.  If the person is happy for me to contact them, please leave their contact details 
(name,  number  &  address)  on  the  accompanying  sheet  and  place  in  my  tray. 
Alternatively you may contact me on the above number or email address to pass on 
this information.
3.  When I have spoken to the person, I will contact you to let you know whether or 
not they have decided to take part in the study.  If they do take part, after I have 
assessed them I will contact you to go through a brief questionnaire which asks about 
their social  and  community  functioning.  If they consent  for a summary  of their 
results to  be  included  in their  file  I will  provide  you with a  brief report  of this 
information.
Thank you.




Study title:  Brief Cognitive Assessment in First Episode Psychosis
You are invited to take part in a research study.  Before you decide, it is important 
for you to understand why the research is being done and what it will involve.  Please 
take some time to read the following information carefully.  Talk to others about the 
study if you wish.
What is the purpose of the study?
Research has suggested that some individuals with psychosis have difficulties with 
memory, attention and thinking.  However, most of this research has looked at 
individuals who have had psychosis for a long time.  The purpose of this study is to 
see if individuals with a more recent onset of psychosis have difficulties with 
memory, attention and thinking.  This could mean that in the future, interventions 
could be developed for people suffering from psychosis, to help them better manage 
their memory, attention and thinking.
Why have I been chosen?
You have been chosen because you are a patient who is under the care of an early 
intervention service.
Do I have to take part?
No, you do not have to take part in this study.  It is up to you to decide whether or 
not to take part.  If you do decide to take part, you will be given this information 
sheet to keep and you will be asked to sign a consent form.  You are still free to 
withdraw from the study at any time and without giving a reason.  A decision to 
withdraw at any time, or a decision not to take part in this study, will not affect the 
standard of health care you receive.
What will happen to me if I take part?
If you decide to take part, you will be asked to attend the early intervention service 
for one appointment.  This appointment is expected to last for one hour and thirty 
minutes, however the time taken to complete the study may vary with each 
participant.  During your visit, you will have an opportunity to ask any questions you 
may have about the study.  You will then be asked to complete some tasks that 
examine memory, attention and thinking.  You may find some of these tasks easy, 
while others may be more difficult. You will also be asked a few details about 
yourself, such as your age and educational background.  You may be asked to have 
your responses on one of the study questionnaires audio recorded.  This is so that the 
accuracy of my ratings can be checked by another researcher who is involved in the 
study.  This is entirely optional, and if you decide not to be recorded you may still 
participate in the study.  Any information you provide will be treated in confidence. 
You will receive £15 for your participation.
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There are no major disadvantages or risks.  Most people feel a little anxious when 
performing a task they are unfamiliar with.  However, no one gets all the tasks 
completely right, and all that is required is your best effort.
What are the possible benefits of taking part?
You will have the opportunity to consent to a brief summary of your results being 
included in your file at the early intervention service.  This may be helpful for those 
involved in your care.  However, if you would not like your scores to be put in your 
file you do not have to consent to this.
What if there is a problem?
It is unlikely that any problems will arise, but if you are unhappy participating 
in the study you are free to withdraw at any time.  If you wish to complain 
about any aspect of the way you have been approached or treated during the 
course of this study, the normal National Health Service complaints 
mechanisms may be available to you.  If you are harmed and this is due to 
someone’s negligence then you may have grounds for legal action for 
compensation against East London and the City Mental Health Trust, but you 
may have to pay your legal costs.  The Patient Advice and Liaison Service 
(PALS) at the East London and The City Mental Health NHS Trust is available 
to help if you need advice or have concerns.  They may be contacted on 
Freephone:  .
Will my taking part in the study be kept confidential?
Yes.  Any information you provide in the study will be kept strictly confidential, and 
will not be passed on to a third party.  You will have an opportunity to consent to a 
brief summary of your results being included in your file at the early intervention 
service.  All documents related to your participation will be stored in a locked 
cupboard, and only those people involved in the study will be able to view them.  If 
you consent to having your responses on one of the study questionnaires audio 
recorded, the tape will be listened to by another researcher and then destroyed within 
1  month of your participation.  The rest of the data will be stored for up to 3 years 
and then destroyed.  If you participate in the study you will be given a unique patient 
identifier code and your name will not appear on any of the documents.
What will happen to the results of the research study?
The results of the study will form part of a dissertation for post graduate 
qualification.  At a later date the results may be published in a scientific journal.
You will not be identified in any reports resulting from this study, and you will have 
the option of being notified of any publication that emerges from the study.
Who has reviewed the study?
This study has been approved by the East London and City Research Ethics 
Committee.
Thank you for taking the time to read this information sheet 
Allison Whitty, Trainee Clinical Psychologist
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Title of project:  Brief Cognitive Assessment in First Episode Psychosis
Name of Researcher:  Allison Whitty
1.  I confirm that I have read and understood the information sheet dated.........
for the above study.  I have had the opportunity to consider the information, ask 
questions and have these answered satisfactorily.
YES / NO (Please circle) (Please initial)
2.  I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights being 
affected.
YES/NO (Please circle) (Please initial)
3.  When I have completed the study, I wish to have a brief summary of my results 
included in my file.
YES / NO (Please circle) (Please initial)
4.  If the results of the study are published, I wish to be informed where I may access 
the publication.  I understand that I need to provide a postal address where I may be 
contacted.
YES / NO (Please circle)
If YES, address:......................................










CONSENT FORM FOR AUDIO RECORDING
Title of project:  Brief Cognitive Assessment in First Episode Psychosis 
Name of Researcher:  Allison Whitty
As  part of this  research we would  like to  audio  record  some of the  participants’ 
responses on one of the questionnaires only (the brief psychiatric rating scale).  This 
is  so  that  another  researcher  (a  clinical  psychologist  from  University  College 
London) can listen to the tape and rate the questionnaire separately from the main 
researcher  (Allison  Whitty).  We  will  then  compare  our  ratings  and  reach  an 
agreement where there are any differences.  This will improve the accuracy of our 
ratings.
As with all the study materials your name or any  identifying information will not 
appear on the cassette tape.  The tape will be stored at UCL until listened to by the 
clinical psychologist and then destroyed within a month of your participation in the 
study.  Only Allison Whitty and the clinical psychologist will have access to the tape 
and no copies will be made.
If you  decide  not to  give  consent  for audio  recording,  the  standard  of care  you 
receive at the early intervention service will not be affected and you may still take 
part in the study.  If you do provide consent for tape recording you may withdraw 
this consent at anytime and the tape will not be used.
1.  I confirm that I have read and understood the above information.  I have had the 
opportunity to consider the information, ask questions and have these answered 
satisfactorily.
YES / NO (Please circle)  (Please initial)
2.  I understand that being tape recorded is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal rights being 
affected.
YES / NO (Please circle) (Please initial)
3.  I AGREE/DO NOT AGREE (please circle) for my responses on the Brief 




127Appendix 5: Report TemplateSUB-DEPARTMENT OF CLINICAL 
HEALTH PSYCHOLOGY
UCL PSYCHOLOGY
Confidential Report -  The results of this report should only be interpreted or 
discussed with the patient by a clinical psychologist.
RE:  Patient’s name and d.o.b.
Address:
Date of report:
Mr./Ms....  consented to participate in a research project entitled “Brief Cognitive 
Assessment in First Episode Psychosis”.  The research project was approved by East 
London and The City Research Ethics Committee, and was carried out by Allison 
Whitty as part of her Doctoral training in Clinical Psychology.  Mr./Ms.... was tested 
on dd/mm/yyyy and consented for a summary of their results to be included in their 
file  at  Tower  Hamlets  Early  Intervention  Service  (THEIS)/Hackney  Early 
Intervention Service (EQUIP).  It should be noted that as with all neuropsychological 
tests,  these  results  may  have  been  influenced  by  factors  such  as  motivation,
medication  and  mood  and  so  may  not  give  a  complete  picture  of Ms./Mr  ’s
ability.
Behaviour during the session
Mr./Ms.... arrived on time for the assessment.  He/she co-operated well with the 
assessment process and completed all measures administered.
Brief Cognitive Assessment Battery (BCA; Velligan et al. 2004)
The  BCA  consists  of  three  standardised  tests  commonly  used  in  clinical 
neuropsychology:  Trails  A  and  B  (Reitan,  1958),  Verbal  Fluency  (Benton  & 
Hamsher, 1976) and the Hopkins Verbal Learning Test (Brandt, 1991).
i) Trails A and B
Trails A measures psychomotor speed while Trails B measures psychomotor speed 
and  divided  attention.  Trails  A consists  of a  series  of numbered  circles (1-25), 
scattered  at  random  on  a worksheet.  The  participant  is  required to  draw  a  line 
between the circles  in numerical order as quickly as possible.  Trails B  has  both 
numbers and letters arrayed in a random order.  The participant is required to draw 
lines between numbers and letters in an alternating sequence (i.e. 1-A, 2-B, 3-C etc.). 
The score is based on time alone.  Mr./Ms.... completed Trails A in ? seconds and 
Trails B in ? seconds.  The time taken to complete Trails A/Trails B/both tests were 
lower/higher/ within the normal range when compared with normative data (Seines et 
al., 1991).
ii) Hopkins Verbal Learning Test (HVLD
129The HVLT is a list learning exercise that assesses verbal memory.  It consists of a list 
of twelve nouns, which are drawn from three different semantic categories, with four 
nouns coming from each category.  The list is read aloud to the participant and their 
free recall of the list is recorded.  The procedure is repeated twice making a total of 
three trials.  After a delay of 20-25 minutes the participant is asked if they can recall 
any words from the list.  Mr./Ms... recalled ? words in total from the first three trials. 
This was lower/higher/ within the normal range when compared with normative data 
(Brandt, 1991).  Mr./Ms.... recalled ? words from the delayed recall trial.  This score 
is  lower/higher/  within  the  normal  range  when  compared  with  normative  data 
(Brandt, 1991).
iip Verbal fluency
Verbal  Fluency  is  a  test of executive  function.  In the  first part of the  task the 
participant is asked to generate as many words as possible beginning with a letter of 
the alphabet (F, A or S).  In the second part the participant is asked to generate as 
many words as possible from a category of animals.  The score is the total number of 
words generated in each category in one minute.  Mr./Ms.... generated ? words for 
letter fluency, and ? words for category fluency.  Compared to normative data this 
score is higher/lower/within the normal range (Seines et al., 1991).
Theoiy of Mind (ToM) tasks
ToM may be defined as the capacity to infer one’s own and other people’s mental 
states  (thoughts,  intentions  and  beliefs)  and  to  use  this  capacity  to  predict  and 
understand behaviours.  There were three ToM tasks used in this study: Hints Task 
(Corcoran et al.,  1995), Picture Sequencing Task, (Langdon et al.,  1997) and ToM 
Stories (Frith & Corcoran,  1996).  As yet there are no normative data available for 
comparison so the results are compared with those of control subjects from published 
studies.
i) Hints Task
This  task  consists  of ten  short  vignettes.  Each  vignette  is  read  aloud  to  the 
participant.  The participant is asked to infer what the story character really meant by 
what he/she said.  If an inference is not made or if an inappropriate conclusion is 
drawn, the participant is given additional information in the form of a more obvious 
hint.  Mr./Ms.... scored ? out of 20.  This score was higher/lower/equal to scores by 
control subjects (Corcoran et al., 1995).
ii) Picture Sequencing Task
This task consists of stories depicted in black and white drawings.  Each story is 
presented  on  four  cards.  There  are  2  practice  sequences  and  3  experimental 
sequences:  social script, mechanical and false belief.  Social script stories depict 
people acting out everyday social routines and test logical routines using social script 
knowledge (involving no appreciation of mental states).  Mechanical stories depict 
cause and  effect sequences and test  ability to  infer causal  relations.  False belief 
stories depict the story character acting on the basis of false beliefs; these stories are 
the test of Theory of Mind. There are 4 stories in each sequence.  The participant is 
presented with each set of story cards placed face down and is required to turn the 
cards over and to order them in a logical sequence.  The order of card placement and
130the time taken to complete each scenario is recorded.  Mr./Ms.... scored an average 
of ? in the social script sequence, ? in the mechanical sequence and ? in the false 
belief sequence.  The  maximum  score achievable  per sequence  is  6.  Relative to 
controls, these scores were in the higher/lower/equal to range.  Mr./Ms. completed 
the social script task in ? seconds, the mechanical task in ? seconds and the false 
belief  task  in  ?  seconds.  Relative  to  controls,  these  timings  were  in  the 
higher/lower/equal to range (Langdon et al., 1997).
iii)  ToM Stories
Four ToM story tasks were read aloud to the participant.  Two of the stories were 
‘first order’ in which a story character has a false belief about a particular situation. 
The other two stories were ‘second order’ in which a story character has a false belief 
about  the  belief  of  another  character.  While  the  stories  were  read  aloud, 
corresponding  cartoon  pictures  were  shown.  The  participant  had  to  answer two 
questions for each story.  The first question assessed ToM, and the second  was a 
control question that tested the participant’s understanding and memory of the story. 
Scores  were  only  considered  when the  second  question  (memory)  was  answered 
correctly.  The participant was given one point for each of the first and second order 
questions.  Mr./Ms.  answered  ? of the  memory  questions  correctly/incorrectly  so 
their scores on this task were/were not considered.  On the first order belief questions 
Mr./Ms. score ? out of 2.  On the second order belief questions Mr./Ms. scored ? out 
of 2 (Frith & Corcoran, 1996).
Weschler Abbreviated Scale of Intelligence (WASI; Psychological Corporation, 
1999)
The WASI provides a reliable and brief test of intelligence quotient (IQ) comparable 
to the  Weschler Adult Intelligence  Scale 3rd  edition (WAIS-III).  The two-subtest 
form  of the  WASI,  including  Vocabulary  and  Matrix  Reasoning,  provides  an 
estimate  of  full  scale  IQ  only.  The  Vocabulary  subtest  is  a  test  of  verbal 
comprehension.  The participant is read aloud a list of words of increasing difficulty 
and is asked to report the meaning of each word.  Matrix Reasoning is a nonverbal 
perceptual reasoning task  in which the participant is asked to  complete a missing 
portion of abstract patterns.  The combined score on the Vocabulary and  Matrix 
Reasoning subtests gives Mr./Ms.... a full scale IQ of ? (confidence interval ?-?).
British Psychiatric Rating Scale (BPRS; Ventura et al, 1993)
The  BPRS  is  a  clinician-rated  tool  designed  to  assess  the  nature  and  extent  of 
psychopathology  in  patients  with  psychotic  illness  over  the  two  weeks  prior  to 
interview. Participants are interviewed in a semi-structured way and are rated on 24 
different  symptom constructs  according to  a  seven-point  scale  ranging  from  ‘not 
present’ to ‘extremely severe’.  A total score is obtained from these ratings.  Mr./Ms. 
scored ? on the BPRS.  Items which received a score between moderate (a score of 3) 
and extremely severe (a score of 7) were......
Summary




Trainee Clinical Psychologist, UCL
Supervised by..............
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5.  Language spoken at home.................................
6.  Years of education.............................................
7.  Employed or unemployed..................................
8.  Residential status..............................................
9.  Diagnosis..........................................................
10.  Age of onset....................................................
11.  Duration of illness.............................................
12.  Number of relapses.............................................
13.  Type of neuroleptic medication........................
and dosage.....................................
14.  Any other psychiatric medication.....................
and dosage......................................
15.  Whether or not used illicit drugs in past month.........
and type of drug(s) used............................................
16.  Drank alcohol in past 24 hours..................................
17.  Caffeine in past 12 hours..........................................